var title_f7_29_7632="Solitary pulmonary nodule CT I";
var content_f7_29_7632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant pulmonary nodule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 269px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lung window setting (from the same patient as radiograph 10) shows scattered spiculations as well as Rigler's notch in this malignant solitary pulmonary nodule. Pleural plaques are again visible (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7632=[""].join("\n");
var outline_f7_29_7632=null;
var title_f7_29_7633="Lofepramine: International drug information";
var content_f7_29_7633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lofepramine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Deftan (ES);",
"     </li>",
"     <li>",
"      Deprimil (PT);",
"     </li>",
"     <li>",
"      Emdalen (ZA);",
"     </li>",
"     <li>",
"      Feprapax (GB);",
"     </li>",
"     <li>",
"      Gamanil (GB, IE);",
"     </li>",
"     <li>",
"      Gamonil (CH, DE);",
"     </li>",
"     <li>",
"      Lomont (GB);",
"     </li>",
"     <li>",
"      Tymelyt (AT, BE, CZ, DK, LU, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidepressant, Tricyclic (Tertiary Amine)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of depression",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 140-210 mg/day in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Suspension, oral: 70 mg/5 mL (150 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet: 70 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10406 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-197.136.42.3-3357F5F93E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7633=[""].join("\n");
var outline_f7_29_7633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304027\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979331\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979334\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979328\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821100\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979333\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10406\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10406|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7634="Eczema herpeticum hand";
var content_f7_29_7634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eczema herpeticum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hemorrhagic crusts and vesicles due to herpes simplex virus infection are present on the hand of this infant with underlying atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig S, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7634=[""].join("\n");
var outline_f7_29_7634=null;
var title_f7_29_7635="HIV and pregnancy";
var content_f7_29_7635=[" <h1 id=\"patTopicTitle\">",
"  Patient information: HIV and pregnancy (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/29/7635/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7635/contributors\" id=\"au3128\">",
"       Brenna Anderson, MD, MSc",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7635/contributors\" id=\"au3127\">",
"       Susan Cu-Uvin, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/29/7635/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7635/contributors\" id=\"se4235\">",
"       Lynne M Mofenson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/29/7635/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7635/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?7/29/7635?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HIV AND PREGNANCY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Infants can become infected with HIV from their mothers during pregnancy, labor and delivery, and, to a lesser degree, through breastfeeding. Fortunately, the use of certain HIV medications during pregnancy and labor can dramatically reduce the risk of passing HIV to the infant.",
"    </p>",
"    <p>",
"     However, not all women are aware that they are infected with HIV. Therefore, experts strongly recommend that",
"     <strong>",
"      all",
"     </strong>",
"     pregnant women undergo screening for HIV infection. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      \"Patient information: Testing for HIV (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     This topic review discusses factors that can reduce HIV transmission from mothers to babies in developed countries such as North America. Therapies that may be useful in the developing world are reviewed elsewhere.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CARE BEFORE PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     Women who have HIV should talk to their HIV specialist before trying to become pregnant. Some HIV medications are not safe to take during pregnancy, and it may be necessary to switch before trying to conceive. It is also important to take your HIV medications regularly. Women who have complete viral suppression (no virus detected in their blood) have a much lower risk of passing HIV to their baby than women who have virus detected in their blood.",
"    </p>",
"    <p>",
"     A number of studies have been done to better understand how HIV infection and HIV treatment affect the health of women and infants. Pregnancy does not appear to worsen HIV or increase the risk of death from HIV. It is not clear if HIV or HIV treatments increase the risk of pregnancy complications, such as prematurity, low birth weight, and stillbirth. However, it is very clear that certain HIV medications, such as zidovudine (ZDV or AZT) and other medications that cross the placenta, can significantly reduce the risk that the newborn will become infected with HIV when the medication is taken during pregnancy and labor, and then given to the newborn after delivery. That is why HIV treatment guidelines strongly recommend a combination of medications to prevent the transmission of HIV to a newborn from an HIV-infected mother. Generally, zidovudine is given with other medications for HIV as part of a three-drug regimen. Some HIV medications, such as efavirenz, should not be used among women who are planning pregnancy. (See",
"     <a class=\"local\" href=\"#H5\">",
"      'HIV medication regimens'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     Talk to your healthcare provider about the risks and benefits of taking HIV medications during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CARE DURING PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     Women with HIV usually require the assistance of several healthcare providers during pregnancy, including an HIV specialist, primary care provider, and obstetrical care provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Initial evaluation",
"     </span>",
"     &nbsp;&mdash;&nbsp;After your pregnancy is confirmed, you should meet with your HIV specialist and obstetrical provider. During these visits, you will discuss how to manage your HIV during pregnancy and minimize the risk of passing HIV to your infant.",
"    </p>",
"    <p>",
"     During the initial evaluation, you will have blood tests to determine the amount of HIV virus in your blood (eg, HIV viral load) and the strength of your immune system (eg, the number of CD4 T cells). You may also have other blood tests to evaluate general health and to monitor side effects of medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h3\">",
"      HIV medication regimens",
"     </span>",
"     &nbsp;&mdash;&nbsp;During pregnancy, most women with HIV are advised to take combination antiretroviral regimens using three HIV drugs. When possible, zidovudine (ZDV) is included because it has been shown to significantly reduce the risk of passing HIV to the infant and is thought to be safe to take during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Timing of HIV medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies suggest that women who start HIV medications earlier in pregnancy are more likely to have a low amount of virus in the blood by the time of delivery. However, some women may prefer to start after the first trimester of pregnancy to avoid unnecessary drug exposure to the baby. You should discuss this with your doctor. Once started, HIV medications are continued throughout pregnancy to prevent HIV transmission to the baby.",
"    </p>",
"    <p>",
"     Even if zidovudine is not used during pregnancy, it is still recommended for some women during labor and for the newborn for six weeks after birth. Information about other HIV medications is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/31/15861?source=see_link\">",
"      \"Patient information: Initial treatment of HIV (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/56/2946?source=see_link\">",
"      \"Patient information: Tips for taking HIV medications (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Medication adherence during pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is extremely important to take your medications exactly as prescribed during pregnancy to decrease the risk of developing drug resistance. Furthermore, taking your medications on time can lessen the risk of HIV transmission to the baby.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Medications to avoid",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are several HIV medications that should not be used in pregnancy: these include the combination of stavudine (d4T) and didanosine (ddI) used together. Nevirapine is generally not started in women with a CD4 count",
"     <span class=\"nowrap\">",
"      &gt;250/mm",
"      <sup>",
"       3",
"      </sup>",
"      .",
"     </span>",
"    </p>",
"    <p>",
"     Efavirenz",
"     should not be started during the first trimester of pregnancy. However, women who become pregnant while taking efavirenz can continue that medication.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Monitoring during pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Throughout your pregnancy, you will see your obstetrical provider and HIV specialist at regular intervals. During these visits, you will have routine obstetrical care as well as HIV monitoring, including blood testing of your CD4 count and HIV viral load.",
"    </p>",
"    <p>",
"     A detailed ultrasound is usually recommended at 18 to 20 weeks of pregnancy to evaluate the growing fetus. A follow-up ultrasound is often recommended during the second",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     third trimester to monitor the fetus' growth.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      LABOR AND DELIVERY WITH HIV",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2583808\">",
"     <span class=\"h2\">",
"      Medications during labor",
"     </span>",
"     &nbsp;&mdash;&nbsp;The HIV drug zidovudine is given during labor when the woman does not have a low amount of HIV in the blood near the time of delivery, regardless of how the woman delivers. In these cases, zidovudine helps to reduce the risk of HIV transmission. Women who are taking combination HIV medications should continue them on schedule during labor or before a cesarean section; this helps to provide maximal protection to the mother and infant and to minimize the risk that the mother could develop drug resistance due to a missed dose of medication.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2583815\">",
"     <span class=\"h2\">",
"      Delivery method",
"     </span>",
"     &nbsp;&mdash;&nbsp;The safest way for women with HIV to deliver a baby (ie, by vaginal or cesarean delivery), depends upon her HIV viral load during pregnancy. The benefit of a scheduled cesarean delivery is that it minimizes the infant's exposure to the mother's blood and vaginal fluids in the birth canal. However, vaginal delivery is the safer option for the mother. The risks are that a cesarean delivery can lead to complications in the mother (bleeding, infection, etc), and it may be more difficult to recover after a cesarean compared with a vaginal delivery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Undetectable viral load",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnant women with HIV who have been taking HIV medications throughout pregnancy and have an undetectable HIV viral load at 34 to 36 weeks of pregnancy may choose to have a vaginal delivery. In this situation, the risk of transmitting HIV to the infant during a vaginal delivery is very low, and it is not clear that a cesarean delivery will decrease this risk any further [",
"     <a class=\"abstract\" href=\"UTD.htm?7/29/7635/abstract/1\">",
"      1",
"     </a>",
"     ]. You should discuss the risks and benefits of cesarean versus vaginal delivery with your obstetrical provider. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=see_link\">",
"      \"Patient information: C-section (cesarean delivery) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Viral load &ge;1000 copies/mL",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnant women with HIV who have taken HIV medications throughout pregnancy but have a viral load above 1000",
"     <span class=\"nowrap\">",
"      copies/mL",
"     </span>",
"     at 34 to 36 weeks of pregnancy are usually advised to have a cesarean delivery rather than a vaginal delivery [",
"     <a class=\"abstract\" href=\"UTD.htm?7/29/7635/abstract/1\">",
"      1",
"     </a>",
"     ]. In this situation, the cesarean is usually scheduled at 38 weeks of pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Viral load &lt;1000 copies/mL",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women with an HIV viral load between 0 and 1000",
"     <span class=\"nowrap\">",
"      copies/mL",
"     </span>",
"     who have been taking HIV medications during pregnancy may choose between a vaginal or cesarean delivery. There is not enough information from studies to know if cesarean delivery decreases the already small risk of passing HIV to the newborn [",
"     <a class=\"abstract\" href=\"UTD.htm?7/29/7635/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      CARE AFTER DELIVERY",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      For women after delivery",
"     </span>",
"     &nbsp;&mdash;&nbsp;After delivery, women who took HIV medications during pregnancy should discuss the benefits that continuing HIV medications has on her own health with her doctor. This decision is best made along with an HIV specialist. Ongoing care and support services, including HIV-related medical care, psychosocial support, and assistance with family planning and birth control, can help the woman to care for the needs of herself and her family. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"      \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Breastfeeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women with HIV who breastfeed can pass HIV to the infant. In one study of over 600 mother-infant pairs from Malawi, the risk of transmitting HIV to the infant through breastmilk was 7 percent for infants who breastfed for one year and 10 percent for infants who breastfed for up to two years.",
"    </p>",
"    <p>",
"     In the United States and other resource-rich countries, clean water and infant formulas are readily available and are safe alternatives to breastfeeding. Therefore, the United States Public Health Service recommends that women in resource-rich countries who are infected with HIV not breastfeed their babies, even if the woman is taking HIV medications. While risk of HIV transmission through breast milk can be lowered by HIV medications, HIV can still be transmitted through breastmilk, even if the woman is taking HIV medications.",
"    </p>",
"    <p>",
"     The same advice cannot be given to women in resource-poor countries because safe alternatives to breastmilk (eg, clean water and formula) may not be consistently available.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      For newborns and infants",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      HIV treatment regimens",
"     </span>",
"     &nbsp;&mdash;&nbsp;Newborns of women with HIV are usually treated with zidovudine for the first six weeks of life. Zidovudine can help to prevent the infant from becoming infected with HIV as a result of exposure to the mother's blood during delivery.",
"    </p>",
"    <p>",
"     In certain situations, another HIV medication may be given instead of or in addition to zidovudine. Talk to your child's healthcare provider to determine which HIV medication is best.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Testing infants for HIV",
"     </span>",
"     &nbsp;&mdash;&nbsp;Normally, adults and children undergo HIV antibody testing to see if they are infected with HIV. However, HIV antibody tests are not accurate in infants since HIV antibodies may be transferred from the mother to the baby. This may result in the infant having a positive HIV antibody test. However, this does not mean that the baby necessarily has HIV infection.",
"    </p>",
"    <p>",
"     For this reason, a special test that directly measures the virus itself is performed in infants to see if they are infected. If this specialized virus test (called HIV PCR test) is negative, then the baby is not infected with HIV.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Long-term follow-up of children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies of infants who were exposed to zidovudine and who did not become infected with HIV have not shown any increased risk of serious problems with growth, the immune system, brain function, cancers, or other problems for up to six years [",
"     <a class=\"abstract\" href=\"UTD.htm?7/29/7635/abstract/2\">",
"      2",
"     </a>",
"     ]. However, long-term data regarding the safety of HIV medications during pregnancy, particularly combination regimens, are not available. As a result, infants and children who were exposed to antiretroviral drugs during their mother's pregnancy should be monitored over their lifetime.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804510279\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3046387049\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21907?source=see_link\">",
"      Patient information: HIV/AIDS (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/44/22210?source=see_link\">",
"      Patient information: Starting treatment for HIV (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/41/36498?source=see_link\">",
"      Patient information: Vaccines for people with HIV (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3046387086\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      Patient information: Testing for HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/31/15861?source=see_link\">",
"      Patient information: Initial treatment of HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/56/2946?source=see_link\">",
"      Patient information: Tips for taking HIV medications (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=see_link\">",
"      Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=see_link\">",
"      HIV and women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13384?source=see_link\">",
"      Non-antiretroviral interventions to reduce perinatal HIV transmission in the developing world",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9786?source=see_link\">",
"      When to initiate antiretroviral therapy in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35525?source=see_link\">",
"      Diagnostic testing for HIV infection in infants and children younger than 18 months",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/23/29050?source=see_link\">",
"      Prevention of HIV transmission during breastfeeding in resource-limited settings",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25290?source=see_link\">",
"      Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/aidsandpregnancy.html\">",
"      www.nlm.nih.gov/medlineplus/aidsandpregnancy.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/hiv/topics/perinatal/index.htm\">",
"      www.cdc.gov/hiv/topics/perinatal/index.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <span class=\"nowrap\">",
"        HIV/AIDS",
"       </span>",
"       Treatment Information Service",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.hivatis.org/\">",
"      www.hivatis.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?7/29/7635/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 18, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?7/29/7635?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. April 29, 2009. www.aidsinfo.nih.gov/Guidelines/ (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7635/abstract/2\">",
"      Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999; 281:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7635/abstract/3\">",
"      Committee on Obstetric Practice. ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet 2001; 73:279.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f7_29_7635=[""].join("\n");
var outline_f7_29_7635=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HIV AND PREGNANCY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CARE BEFORE PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CARE DURING PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           LABOR AND DELIVERY WITH HIV",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           CARE AFTER DELIVERY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7636="Scissors technique to open mouth";
var content_f7_29_7636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scissors technique to open mouth for laryngoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The photograph demonstrates mouth opening using the \"scissors\" technique, in which the thumb and middle finger flex and cross one another. Use of the finger flexors, which are stronger than extensors, make the maneuver easier to perform.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Orebaugh SL. Direct laryngoscopy. In: Atlas of Airway Management: Techniques and Tools, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7636=[""].join("\n");
var outline_f7_29_7636=null;
var title_f7_29_7637="Alprazolam: Patient drug information";
var content_f7_29_7637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alprazolam: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=see_link\">",
"     see \"Alprazolam: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/35/7735?source=see_link\">",
"     see \"Alprazolam: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F132040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alprazolam Intensol&trade;;",
"     </li>",
"     <li>",
"      Niravam&trade;;",
"     </li>",
"     <li>",
"      Xanax XR&reg;;",
"     </li>",
"     <li>",
"      Xanax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F132041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Alpraz&reg;;",
"     </li>",
"     <li>",
"      Apo-Alpraz&reg; TS;",
"     </li>",
"     <li>",
"      Mylan-Alprazolam;",
"     </li>",
"     <li>",
"      NTP-Alprazolam;",
"     </li>",
"     <li>",
"      Nu-Alpraz;",
"     </li>",
"     <li>",
"      Teva-Alprazolam;",
"     </li>",
"     <li>",
"      Xanax TS&trade;;",
"     </li>",
"     <li>",
"      Xanax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10237524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691728",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692010",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat panic attacks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701472",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alprazolam or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for more than 10 days, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697357",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you stop smoking, talk with your doctor. How much drug you take may need to be changed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697935",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in balance.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tablet can be crushed and mixed with food or liquid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral-disintegrating tablet:",
"        </span>",
"       </b>",
"       Place on your tongue and let it melt. Water is not needed. Do not swallow it whole. Do not chew, break, or crush it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694297",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12533 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-1E93B43961-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7637=[""].join("\n");
var outline_f7_29_7637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132040\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132041\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10237524\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014535\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014534\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014539\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014540\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014542\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014537\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014538\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014543\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014544\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=related_link\">",
"      Alprazolam: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/35/7735?source=related_link\">",
"      Alprazolam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7638="Erythema nodosum - close view";
var content_f7_29_7638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema nodosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous nodule is present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7638=[""].join("\n");
var outline_f7_29_7638=null;
var title_f7_29_7639="Lower extremity positional deformations";
var content_f7_29_7639=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lower extremity positional deformations",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Tiffany M McKee-Garrett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7639/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7639/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/29/7639/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positional deformations are abnormalities that are mechanically produced by alterations of the normal fetal environment, which restrict fetal movement",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cause significant fetal compression [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/1\">",
"     1",
"    </a>",
"    ]. Deformations of the extremities occur frequently because fetal movement is required for normal musculoskeletal development.",
"   </p>",
"   <p>",
"    Birth deformations can be divided into the following presentations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Craniofacial abnormalities include scaphocephaly, plagiocephaly, mandibular asymmetry, flattened facies, deviated nasal septum, ear abnormalities, and craniosynostosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=see_link&amp;anchor=H5#H5\">",
"       \"Overview of craniosynostosis\", section on 'Categorization of cranial deformities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital torticollis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/49/43798?source=see_link\">",
"       \"Congenital muscular torticollis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Congenital scoliosis",
"     </li>",
"     <li>",
"      Lower extremity abnormalities including metatarsus adductus, positional calcaneovalgus feet, positional clubfoot, internal and external tibial torsion, and physiologic genu varum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of deformations are due to foot and leg abnormalities, which are reviewed here. Developmental dysplasia of the hips, which is also associated with factors that restrict fetal movement, is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/12/199?source=see_link\">",
"     \"Epidemiology and pathogenesis of developmental dysplasia of the hip\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27113?source=see_link\">",
"     \"Clinical features and diagnosis of developmental dysplasia of the hip\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21254?source=see_link\">",
"     \"Treatment and outcome of developmental dysplasia of the hip\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deformations are caused by problems that are intrinsic and extrinsic to the fetus. Infants with deformations caused by extrinsic causes are generally otherwise healthy. Those with deformations due to intrinsic factors are at increased risk for other fetal abnormalities (eg, renal disease or central nervous system disorder).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrinsic fetal causes include primary neuromuscular disorders resulting in decreased fetal movement, and renal disease resulting in decreased production of amniotic and oligohydramnios, which increases the risk of fetal compression from outside forces.",
"     </li>",
"     <li>",
"      Extrinsic causes are primarily due to factors that lead to fetal crowding and restricted fetal movement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Oligohydramnios from leakage of amniotic fluid",
"     </li>",
"     <li>",
"      Breech position, in which movement of the fetal legs are restricted due to entrapment between the body of the fetus and the uterine wall. Breech position increases the risk of deformations by ten-fold.",
"     </li>",
"     <li>",
"      Abnormalities of the amniotic cavity such as the presence of uterine tumors or deformities (eg, bicornuate uterus or septated uterus)",
"     </li>",
"     <li>",
"      Multiple fetuses or very large fetus",
"     </li>",
"     <li>",
"      Compression of the amniotic cavity affecting its size and shape due to a small maternal pelvis and the size of neighboring maternal organs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During the last trimester, the impact of external factors increases as the fetus grows and the amniotic fluid decreases. As a result, positional deformities are more common in term infants than premature infants. This was illustrated in one study that reported no rotational deformities (eg, medial tibial torsion) in premature infants with gestational ages &le; 30 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The assessment of deformities in the newborn must include a thorough physical examination to detect any neurological or other musculoskeletal abnormality that may have been an intrinsic cause of the deformity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     FOOT DEFORMITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common positional deformities of the feet include metatarsus adductus and positional calcaneovalgus feet and clubfoot (talipes equinovarus). In a study of 2,401 consecutive newborns, the incidence of foot deformities was 4.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/3\">",
"     3",
"    </a>",
"    ]. Seventy-six percent of cases were due to metatarsus adductus, and 18 percent were due to calcaneovalgus feet. Almost all of the patients had normal feet at follow-up at five or six years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Metatarsus adductus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metatarsus adductus is the most common congenital foot deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. It is characterized by medial deviation (adduction) of the forefoot while the hindfoot remains in a normal position, thus forming a \"C\" shape, or concavity of the medial aspect of the foot (",
"    <a class=\"graphic graphic_picture graphicRef57425 \" href=\"UTD.htm?29/44/30414\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The reported incidence is about 1 to 2 per 1,000 live births and is increased in families with a history of metatarsus adductus [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. It appears to occur more commonly in first-born children due to the increased molding effect from the primigravida uterus and abdominal wall. The incidence is higher in twin compared to singleton births but the frequency of metatarsus adductus appears to be similar in premature and term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Clinical findings and assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metatarsus adductus is characterized by medial deviation of the forefoot, which is usually slightly supinated while the hindfoot remains neutral. A deep medial crease is generally present. Metatarsus adductus is often bilateral; when unilateral, it occurs more often on the left than on the right (for unknown reasons) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/7\">",
"     7",
"    </a>",
"    ]. It is the most common cause of in-toeing gait in the infant [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/8\">",
"     8",
"    </a>",
"    ]. In the walking child, abnormal shoe wear may occur.",
"   </p>",
"   <p>",
"    Two classification systems have been used to evaluate the severity of this condition (",
"    <a class=\"graphic graphic_figure graphicRef60426 \" href=\"UTD.htm?24/19/24882\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first is known as the heel bisector, in which the severity of metatarsus adductus is determined by the relationship of the toes to the projected axis of the foot that bisects the heel and normally extends through the second toe. The severity of the condition increases as the heel axis moves more laterally in relationship to the toes. However, the severity based upon this classification schema does not correlate with the prognosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42264?source=see_link&amp;anchor=H25515563#H25515563\">",
"       \"Approach to the child with in-toeing\", section on 'Focused examination of the lower extremities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The second defines severity by the degree of flexibility of the forefoot. Flexibility is based upon the ability to correct the metatarsus adduction by providing lateral pressure on the forefoot over the first metatarsal while firmly holding the heel in a neutral position with the other hand. In infants with flexible metatarsus adductus, spontaneous correction generally occurs. Therapy is reserved for those with rigid (severe) or moderately inflexible metatarsus adductus. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although historically hip dysplasia had been associated with metatarsus adductus, more recent data have demonstrated no association between the two conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. As part of the normal routine care practice, the hips should be examined at every health-supervision visit until the child is walking normally (usually by two years of age). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27113?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of developmental dysplasia of the hip\", section on 'Examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radiographs are generally not necessary in infants with metatarsus adductus. They are indicated for toddlers or older children with persistent deformity to determine if another condition, such as clubfoot and skewfoot (complex foot deformity with medial deviation of the forefoot, lateral translation of the midfoot, and valgus hindfoot), is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42264?source=see_link&amp;anchor=H21546674#H21546674\">",
"     \"Approach to the child with in-toeing\", section on 'Uncommon pathologic causes of in-toeing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all cases of metatarsus adductus (over 90 percent) will resolve without intervention. Treatment, if needed, is dependent upon the severity of the condition based upon the degree of flexibility of the affected foot as follows (",
"    <a class=\"graphic graphic_figure graphicRef60426 \" href=\"UTD.htm?24/19/24882\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild &mdash; &nbsp;Mildly affected feet can be passively overcorrected into abduction with little effort. In these patients, treatment is not necessary as resolution will occur spontaneously over time. Overcorrection with passive and active stretching may lead to mild abduction. As a result, stretching exercises should not be performed in these patients.",
"     </li>",
"     <li>",
"      Moderate &mdash; Moderately deformed feet will passively correct only to the neutral position. Passive stretching exercises are commonly recommended, however, it is unclear whether or not they are efficacious [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/12\">",
"       12",
"      </a>",
"      ]. The exercises consist of laterally directed pressure on the head of the first metatarsal to correct the malalignment; the position should be held for ten seconds; it should be performed five times for per foot whenever the infant&rsquo;s diaper is changed [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although controversial, management with an orthotic splint or corrective shoes has been suggested to benefit infants with moderately flexible metatarsus adductus but these measures have not been shown to be beneficial.",
"   </p>",
"   <p>",
"    Patients should be reevaluated on a regular basis and may require casting if no improvement is seen.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe &mdash; In severe or rigid metatarsus adductus, the forefoot is unable to be passively abducted to the midline. In these cases, corrective casting is required. Results are best with early treatment before eight months of age as the deformity may worsen over time [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/9,12,14\">",
"       9,12,14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one case series of 65 infants with moderate (37 feet) and severe (48 feet) metatarsus adductus, below-knee plaster casting corrected the deformity within six to eight weeks in all cases. At a mean follow-up of four years, correction was maintained in all children with initial moderate deformity; and of the 44 feet with severe deformity available for examination, six had a moderate deformity, one had a severe deformity, and the remaining maintained the correction [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical correction is controversial. It may be an option for the older child with persistent metatarsus adductus, however the reported incidences are high for failure (about 40 percent) and complications (about 50 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Complications include skin slough and persistent pain with prominence of the tarsal metatarsal joints.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the outcome for patients without intervention or non-surgical treatment with metatarsus adductus is excellent. This was illustrated in a case series of 31 patients (45 feet) with metatarsus adductus who were followed for a mean of 32.5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/18\">",
"     18",
"    </a>",
"    ]. At initial presentation, 12 patients (16 feet) with mild deformity received no treatment, and 20 patients (29 feet) with moderate and severe deformity were treated with serial manipulation and casting, one patient had bilateral involvement with no treatment on one foot and intervention on the other. No patient was treated with surgical correction. Excellent results were seen in all patients with mild deformity without treatment and in 90 percent of the more severely affected feet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Positional calcaneovalgus feet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positional calcaneovalgus feet, also referred to as talipes calcaneovalgus, is a common foot deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/3\">",
"     3",
"    </a>",
"    ]. It is characterized by hyperdorsiflexion of the foot with the abduction of the forefoot, which often results in the forefoot resting on the anterior surface of the lower leg (",
"    <a class=\"graphic graphic_picture graphicRef58256 \" href=\"UTD.htm?5/40/5762\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72144 \" href=\"UTD.htm?34/59/35761\">",
"     picture 3",
"    </a>",
"    ). External tibial torsion is a common associated finding.",
"   </p>",
"   <p>",
"    It is a deformity that is thought to be more common in first-born children due to the increased molding effects of the primigravida uterus.",
"   </p>",
"   <p>",
"    Differentiating calcaneovalgus feet, which is generally benign, from the following more severe conditions is mandatory [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital vertical talus, also referred to as \"rocker-bottom foot\", is a rare condition, which is frequently associated with neuromuscular and genetic disorders (eg, trisomy 13 through 15). Congenital vertical talus has a fixed dislocation of the navicular dorsolaterally on the head of the talus. The ability to correct (or partially correct) the deformity with gentle pressure usually distinguishes the more flexible calcaneovalgus feet from the rigid congenital vertical talus [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/19\">",
"       19",
"      </a>",
"      ]. In cases where the examination is inconclusive, a radiograph can differentiate between the two conditions.",
"     </li>",
"     <li>",
"      Paralytic calcaneus foot deformity is seen in infants with a neuromuscular disorder (eg, myelodysplasia or polio), which results in the absence or paralysis of the gastrocsoleus muscle. The physical examination should differentiate between paralytic and positional calcaneovalgus feet by detecting a motor deficit in the former condition. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19688?source=see_link\">",
"       \"Orthopedic issues in myelomeningocele (spina bifida)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Posteromedial bow of the tibia is a condition, which includes both a calcaneovalgus foot and a bowed, shortened tibia. Examination will detect a leg-length discrepancy. Bowing of the tibia can also be seen by radiography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most cases of positional calcaneovalgus feet will spontaneously resolve [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/3,19\">",
"     3,19",
"    </a>",
"    ]. If the foot cannot be plantar-flexed below neutral, casting is indicated. Surgical treatment is not required [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Positional clubfoot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clubfoot, also referred to as talipes equinovarus, is a complex condition that involves both the foot and lower extremity. It is characterized by the foot being excessively plantar flexed, with the forefoot swung medially and the sole facing inward.",
"   </p>",
"   <p>",
"    Club feet can be can be classified as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital clubfoot is the most common type. It is usually an isolated anomaly without a well-delineated etiology. Current management is based upon manipulation that includes casting and bracing (referred to as the Ponseti method) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/20-22\">",
"       20-22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Syndromic clubfoot is associated with intrinsic etiologies of clubfeet including connective tissue, genetic or neuromuscular disorder, or syndrome (",
"      <a class=\"graphic graphic_table graphicRef78890 \" href=\"UTD.htm?40/20/41292\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=see_link&amp;anchor=H5#H5\">",
"       \"Prenatal diagnosis of talipes equinovarus (clubfoot)\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Positional clubfoot is due to intrauterine crowding or breech position. It is not a true club foot. It is a normal foot that has been held in a deformed position in utero (",
"      <a class=\"graphic graphic_picture graphicRef80612 \" href=\"UTD.htm?42/41/43664\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef58339 \" href=\"UTD.htm?35/39/36465\">",
"       picture 5",
"      </a>",
"      ). The positional clubfoot easily corrects to a normal position with manipulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prenatal diagnosis of clubfoot is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=see_link\">",
"     \"Prenatal diagnosis of talipes equinovarus (clubfoot)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ROTATIONAL DEFORMITIES OF THE LEGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rotational variations of the foot position to the leg often occur in younger children due to in-uterine positioning. In utero, the fetus's hips are typically flexed, abducted, and externally rotated while the lower legs are internally rotated and the knees flexed. With intrauterine crowding and mechanical restriction, this position predisposes the fetus to rotational deformities that include internal and external tibial torsion and external rotation of the hips, which may result in physiologic genu varum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Internal tibial torsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Internal tibial torsion is a normal rotational variant and is a result of intrauterine positioning. It is the most common cause of in-toeing in toddlers as they begin to walk. It may also be associated with metatarsus adductus and genu varum. Internal tibial torsion is bilateral in approximately two-thirds of cases; in unilateral cases the left side is more commonly involved for unknown reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On examination, the infant with internal tibial torsion will have a medially deviated foot when the patella is facing directly forward. The degree of torsion or rotation can be measured by the thigh-foot angle, the angular difference between the axis of the foot and the axis of the thigh when the patient is in the prone position with the knees flexed 90 degrees and the foot and ankle in neutral position (",
"    <a class=\"graphic graphic_figure graphicRef68556 \" href=\"UTD.htm?34/22/35169\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42264?source=see_link&amp;anchor=H25515563#H25515563\">",
"     \"Approach to the child with in-toeing\", section on 'Focused examination of the lower extremities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous resolution of internal tibial torsion occurs with ambulation and normal growth, so no intervention is generally required. Surgical treatment is rarely indicated and is reserved for the older child with marked functional or cosmetic deformity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42264?source=see_link&amp;anchor=H21546758#H21546758\">",
"     \"Approach to the child with in-toeing\", section on 'Internal tibial torsion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     External tibial torsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;External tibial torsion is a normal rotational variant due to intrauterine positioning. It is the most common cause of out-toeing in infants and young children and is usually identified when the child begins to walk. It is often accompanied by positional calcaneovalgus.",
"   </p>",
"   <p>",
"    On physical examination, the thigh-foot angle is abnormally positive with values between +30 to +50 degrees (",
"    <a class=\"graphic graphic_figure graphicRef68556 \" href=\"UTD.htm?34/22/35169\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This condition typically follows a similar course of internal tibial torsion, with spontaneous resolution over time. However, disability (eg, knee pain patellofemoral instability) is more common in children with persistent external tibial torsion than in those with internal tibial torsion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/26\">",
"     26",
"    </a>",
"    ]. Increased external tibial torsion is also associated with neuromuscular disorders including myelodysplasia and polio [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/24\">",
"     24",
"    </a>",
"    ]. As a result, a careful neurologic examination should be performed in patients with this finding.",
"   </p>",
"   <p>",
"    As with other positional deformities, intervention is usually not required as the majority of affected children will have spontaneous resolution. Significant improvement does not occur until the child has achieved independent ambulation. External tibial torsion is more likely to persist through adolescence than internal tibial torsion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical treatment is rarely indicated and is reserved for the older child with marked functional or cosmetic deformity (ie, thigh-foot values greater than +40 degrees) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7639/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physiologic genu varum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physiologic genu varum, also referred to as \"bowlegs\" is a common deformity due to intrauterine positioning. The deformity is caused by a combination of external rotation at the hip due to the tight posterior hip capsule and internal tibial torsion. It is typically identified in the older infant or toddler shortly after the start of ambulation. Physiologic genu varum generally resolves spontaneously and must be differentiated from pathologic causes such as Blount's disease, which may require intervention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/55/27511?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to the child with bow-legs\", section on 'Physiologic varus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positional deformations are abnormalities that are mechanically produced by alterations of the normal fetal environment that restrict fetal movement",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cause significant fetal compression.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Deformations of the lower extremities occur frequently, because fetal movement is required for normal musculoskeletal development. They include foot deformities and rotational deformities of the legs. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Metatarsus adductus is the most common foot deformity with a reported incidence of 1 to 2 per 1,000 live births. It is characterized by medial deviation of the forefoot while the hindfoot remains neutral. In the vast majority of cases (90 percent), metatarsus adductus resolves spontaneously over time.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the small minority of patients with severe or rigid metatarsus adductus, which is less likely to improve without intervention, we suggest casting to correct the deformity (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Results are best with early treatment before eight months of age.",
"     </li>",
"     <li>",
"      We do",
"      <strong>",
"       not",
"      </strong>",
"      recommend routine surgical correction because of the high rates of failure and complications (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Metatarsus adductus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positional calcaneovalgus feet (hyperdorsiflexion of the foot with the abduction of the forefoot) typically resolve spontaneously without intervention (",
"      <a class=\"graphic graphic_picture graphicRef58256 \" href=\"UTD.htm?5/40/5762\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef72144 \" href=\"UTD.htm?34/59/35761\">",
"       picture 3",
"      </a>",
"      ). In some persistent cases, casting may be indicated. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Positional calcaneovalgus feet'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Positional clubfoot is a normal foot that has been held in a deformed position in utero (",
"      <a class=\"graphic graphic_picture graphicRef80612 \" href=\"UTD.htm?42/41/43664\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef58339 \" href=\"UTD.htm?35/39/36465\">",
"       picture 5",
"      </a>",
"      ). As opposed to a true clubfoot, the positional clubfoot easily corrects to a normal position with manipulation and will resolve spontaneously over time. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Positional clubfoot'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=see_link\">",
"       \"Prenatal diagnosis of talipes equinovarus (clubfoot)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Internal and external tibial torsion are rotational deformities that typically present as in-toeing (internal tibial torsion) and out-toeing (external tibial torsion) when the child begins to ambulate. With normal growth and development, both conditions generally resolve spontaneously without intervention. Surgical treatment is rarely indicated and is reserved for the older child with marked functional or cosmetic deformity. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Internal tibial torsion'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'External tibial torsion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physiologic genu varum (also referred to as physiologic bowing) is a positional deformity that is characterized by external rotational at the hip and internal tibial torsion. It is typically detected in the older infant and toddler shortly after ambulation begins. Physiologic genu varum generally resolves spontaneously and must be differentiated from pathologic causes, such as Blount's disease, which may require intervention. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/55/27511?source=see_link\">",
"       \"Approach to the child with bow-legs\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Graham, JJM (Ed). Smith's Recognizable Patterns of Human Deformation, WB Saunders, Philadelphia 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/2\">",
"      Katz K, Naor N, Merlob P, Wielunsky E. Rotational deformities of the tibia and foot in preterm infants. J Pediatr Orthop 1990; 10:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/3\">",
"      Widhe T, Aaro S, Elmstedt E. Foot deformities in the newborn--incidence and prognosis. Acta Orthop Scand 1988; 59:176.",
"     </a>",
"    </li>",
"    <li>",
"     Glass, SM. Abnormal Physical Findings. In: Assessment and Care of the Well Newborn, Thureen, PJ, et al (Eds), WB Saunders, Philadelphia 1999. p.206.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/5\">",
"      WYNNE-DAVIES R. FAMILY STUDIES AND THE CAUSE OF CONGENITAL CLUB FOOT. TALIPES EQUINOVARUS, TALIPES CALCANEO-VALGUS AND METATARSUS VARUS. J Bone Joint Surg Br 1964; 46:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/6\">",
"      Hunziker UA, Largo RH, Duc G. Neonatal metatarsus adductus, joint mobility, axis and rotation of the lower extremity in preterm and term children 0-5 years of age. Eur J Pediatr 1988; 148:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/7\">",
"      Staheli LT. Rotational problems in children. Instr Course Lect 1994; 43:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/8\">",
"      Li YH, Leong JC. Intoeing gait in children. Hong Kong Med J 1999; 5:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/9\">",
"      Bleck EE. Metatarsus adductus: classification and relationship to outcomes of treatment. J Pediatr Orthop 1983; 3:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/10\">",
"      Gruber MA, and Lozano, JA. Metatarsus varus and developmental dysplasia of the hip: is there a relationship? Orthop Trans 1991;15:336.",
"     </a>",
"    </li>",
"    <li>",
"     Kasser, JR. The foot. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissy, RT, and Weinstein, SL (eds), Lippincott Williams &amp; Wilkins, Philadelphia, 2006. p. 1257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/12\">",
"      Ponseti IV, Becker JR. Congenital metatarsus adductus: the results of treatment. J Bone Joint Surg Am 1966; 48:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/13\">",
"      Scherl SA. Common lower extremity problems in children. Pediatr Rev 2004; 25:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/14\">",
"      Berg EE. A reappraisal of metatarsus adductus and skewfoot. J Bone Joint Surg Am 1986; 68:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/15\">",
"      Katz K, David R, Soudry M. Below-knee plaster cast for the treatment of metatarsus adductus. J Pediatr Orthop 1999; 19:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/16\">",
"      Stark JG, Johanson JE, Winter RB. The Heyman-Herndon tarsometatarsal capsulotomy for metatarsus adductus: results in 48 feet. J Pediatr Orthop 1987; 7:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/17\">",
"      Berman A, Gartland JJ. Metatarsal osteotomy for the correction of adduction of the fore part of the foot in children. J Bone Joint Surg Am 1971; 53:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/18\">",
"      Farsetti P, Weinstein SL, Ponseti IV. The long-term functional and radiographic outcomes of untreated and non-operatively treated metatarsus adductus. J Bone Joint Surg Am 1994; 76:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/19\">",
"      Yu GV, Hladik J. Residual calcaneovalgus deformity: review of the literature and case study. J Foot Ankle Surg 1994; 33:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/20\">",
"      Cooper DM, Dietz FR. Treatment of idiopathic clubfoot. A thirty-year follow-up note. J Bone Joint Surg Am 1995; 77:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/21\">",
"      Ponseti IV, Smoley EN. The classic: congenital club foot: the results of treatment. 1963. Clin Orthop Relat Res 2009; 467:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/22\">",
"      Bridgens J, Kiely N. Current management of clubfoot (congenital talipes equinovarus). BMJ 2010; 340:c355.",
"     </a>",
"    </li>",
"    <li>",
"     Tachdjian MO. The knee and leg. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Appleton and Lange, Stamford 1997. p.87.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/24\">",
"      Lincoln TL, Suen PW. Common rotational variations in children. J Am Acad Orthop Surg 2003; 11:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/25\">",
"      Katz JF. Behavior of internal tibial torsion in infancy. Mt Sinai J Med 1982; 49:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/26\">",
"      Turner MS. The association between tibial torsion and knee joint pathology. Clin Orthop Relat Res 1994; :47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/27\">",
"      Staheli LT. Torsional deformity. Pediatr Clin North Am 1977; 24:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7639/abstract/28\">",
"      Staheli LT. Rotational problems of the lower extremities. Orthop Clin North Am 1987; 18:503.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5030 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-C88E1676B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7639=[""].join("\n");
var outline_f7_29_7639=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      FOOT DEFORMITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Metatarsus adductus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Clinical findings and assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Positional calcaneovalgus feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Positional clubfoot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ROTATIONAL DEFORMITIES OF THE LEGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Internal tibial torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      External tibial torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physiologic genu varum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5030\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5030|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/19/24882\" title=\"figure 1\">",
"      Eval metatarsus adductus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/22/35169\" title=\"figure 2\">",
"      Thigh foot angle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5030|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/44/30414\" title=\"picture 1\">",
"      Metatarsus adductus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/40/5762\" title=\"picture 2\">",
"      Calcaneovalgus feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/59/35761\" title=\"picture 3\">",
"      Calcaneovalgus feet at rest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/41/43664\" title=\"picture 4\">",
"      Positional club feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/39/36465\" title=\"picture 5\">",
"      Positional club foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5030|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/20/41292\" title=\"table 1\">",
"      Causes of clubfoot",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/55/27511?source=related_link\">",
"      Approach to the child with bow-legs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42264?source=related_link\">",
"      Approach to the child with in-toeing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27113?source=related_link\">",
"      Clinical features and diagnosis of developmental dysplasia of the hip",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/49/43798?source=related_link\">",
"      Congenital muscular torticollis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/12/199?source=related_link\">",
"      Epidemiology and pathogenesis of developmental dysplasia of the hip",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19688?source=related_link\">",
"      Orthopedic issues in myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=related_link\">",
"      Overview of craniosynostosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=related_link\">",
"      Prenatal diagnosis of talipes equinovarus (clubfoot)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21254?source=related_link\">",
"      Treatment and outcome of developmental dysplasia of the hip",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7640="DLBCL BCL-2 staining";
var content_f7_29_7640=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Diffuse large B-cell lymphoma BCL-2 staining",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse large B-cell lymphoma, centroblast variant. Membrane staining for BCL-2 in a large number of cells. BCL-2/peroxidase immunostaining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ioachim HL, Medeiros LJ. Diffuse large B-cell lymphoma. In: Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7640=[""].join("\n");
var outline_f7_29_7640=null;
var title_f7_29_7641="Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents";
var content_f7_29_7641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7641/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7641/contributors\">",
"     Stephen LaFranchi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7641/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7641/contributors\">",
"     John L Kirkland, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7641/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/29/7641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of hyperthyroidism in children and adolescents are similar to those seen in adults. In addition, the disorder has unique effects on growth and development. The clinical features of hyperthyroidism are largely independent of the cause. Although there are several potential causes of hyperthyroidism in children, Graves' disease is by far the most common etiology.",
"   </p>",
"   <p>",
"    Graves' disease causes unique problems that are not related to the high serum thyroid hormone concentrations. They include Graves' ophthalmopathy and infiltrative dermopathy (localized or pretibial myxedema). Graves' ophthalmopathy is common in children, but less severe than in adults; dermopathy is almost never found in children. Most patients with Graves' hyperthyroidism have a diffuse goiter, but so do patients with other, less common causes of hyperthyroidism, such as \"Hashitoxicosis\" (silent or painless thyroiditis), subacute thyroiditis, or forms of nonautoimmune hyperthyroidism. These disorders are discussed briefly in this topic review. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Other'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The clinical presentation and laboratory evaluation of children with hyperthyroidism and thyrotoxicosis are discussed here. Treatment of hyperthyroidism is discussed separately. Hyperthyroidism presenting during the neonatal period also is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25400?source=see_link\">",
"     \"Treatment and prognosis of Graves' disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/6/97?source=see_link\">",
"     \"Evaluation and management of neonatal Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Graves' disease is by far the most common cause of hyperthyroidism in children and adolescents. In a national population-based study of thyrotoxicosis from the United Kingdom and Ireland in the year 2004, the annual incidence was 0.9 per 100,000 children &lt;15 years of age, with Graves' disease accounting for 96 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/1\">",
"     1",
"    </a>",
"    ]. Overall, the prevalence of Graves' hyperthyroidism in children is approximately 0.02 percent (1:5000), mostly in the 11- to 15-year age group [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/2\">",
"     2",
"    </a>",
"    ]. In a report of 143 children with Graves' disease, 38 percent were prepubertal at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/3\">",
"     3",
"    </a>",
"    ]. Girls are affected more commonly than boys, at a ratio of about 5:1. The ratio is considerably lower among younger children, suggesting that estrogen secretion in some way affects the occurrence of Graves' disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proximate cause of Graves' hyperthyroidism in children and adolescents, as in adults, is thyrotropin (TSH) receptor-stimulating antibodies (TRS-Ab), which activate the TSH receptor. A population-based study of Danish twins suggested that approximately 80 percent of the risk of Graves' disease is attributable to genetic factors [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/30/40425?source=see_link\">",
"     \"Pathogenesis of Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Graves' ophthalmopathy may result from antibodies against a TSH receptor-like protein in retroorbital connective tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/5\">",
"     5",
"    </a>",
"    ]. A study in children with Graves' disease reported a positive association between elevated levels of thyroid stimulating immunoglobulin (TSI) and the development of ophthalmopathy, further suggesting that the eye complications are a part of the autoimmune process [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3432?source=see_link\">",
"     \"Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many children and adolescents with Graves' hyperthyroidism have a family history of autoimmune thyroid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/7\">",
"     7",
"    </a>",
"    ]. The patients themselves may have an increased frequency of other autoimmune endocrine diseases (eg, diabetes mellitus, celiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/8\">",
"     8",
"    </a>",
"    ], and primary adrenal insufficiency) and nonendocrine disorders (eg, vitiligo, systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/9\">",
"     9",
"    </a>",
"    ], thrombocytopenic purpura, and pernicious anemia). Some patients have antineutrophil antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/10\">",
"     10",
"    </a>",
"    ]. Children with trisomy 21 (Down syndrome) have an increased risk for Graves' hyperthyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/11\">",
"     11",
"    </a>",
"    ]. In a review from Spain, 12 of 1832 patients with Down syndrome were diagnosed with hyperthyroidism (6.5",
"    <span class=\"nowrap\">",
"     cases/1000)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/12\">",
"     12",
"    </a>",
"    ]. In a separate series, Down syndrome patients tended to be diagnosed with hyperthyroidism at an earlier age as compared with children without Down syndrome, and they did not show the usual female preponderance [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    .) Patients with Turner syndrome are also at increased risk for hyperthyroidism; in one series, 2 out of 119 developed Graves' disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the clinical features of hyperthyroidism in children and adolescents are similar to those in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/7,15\">",
"     7,15",
"    </a>",
"    ]. The onset of these manifestations is often insidious, and the changes may be present for months or years before the diagnosis is made. Hyperthyroidism has unique effects in children on growth and pubertal development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acceleration of growth is accompanied by advancement of epiphyseal maturation. The acceleration in growth is usually subtle and depends upon the duration of hyperthyroidism before diagnosis. As an example, in children who have had hyperthyroidism for one to two years, height may increase from the 50th to the 75th percentile. The effect on growth may be more pronounced if hyperthyroidism presents in early childhood. In a report of children aged 3.4 to 7.5 years, median height was +1.25 SD, while BMI was -0.48 SD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/16\">",
"     16",
"    </a>",
"    ]. With antithyroid drug treatment, the abnormalities in growth velocity and bone age approach a more normal pattern. In a report of 101 children with Graves' disease from Italy, bone age was advanced at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/17\">",
"     17",
"    </a>",
"    ]. Nonetheless, adult height was normal after treatment with antithyroid drugs, and was even slightly increased in the boys who were diagnosed during puberty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pubertal development tends to be delayed, and among those in whom it has begun, it slows until the hyperthyroidism is treated. Girls who have undergone menarche may develop secondary amenorrhea. Hyperthyroidism is associated with high sex hormone-binding globulin (SHBG), which may result in high serum estradiol levels in girls and testosterone levels in boys. However, unbound or free levels of these hormones are decreased, perhaps explaining why LH levels are slightly elevated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Eyes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stare and lid lag occur in many children with hyperthyroidism. The symptoms are caused by sympathetic overactivity, possibly mediated by increased alpha-adrenergic receptors in some tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/18\">",
"     18",
"    </a>",
"    ]. Lid lag is evaluated by having the patient follow the examiner's finger as it is moved up and down. The patient has lid lag if sclera can be seen above the iris as the patient looks downward.",
"   </p>",
"   <p>",
"    Ophthalmopathy is characterized by inflammation of the extraocular muscles and orbital fat and connective tissue, which results in proptosis (exophthalmos), impairment of eye muscle function, and periorbital edema. These findings are almost always caused by Graves' disease. Although 50 to 75 percent of children with Graves' disease have some features of Graves' ophthalmopathy, the symptoms tend to be milder than those seen in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. In a series of 152 children with Graves' disease, only 17 percent required referral to an ophthalmologist for management of Graves' eye disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/21\">",
"     21",
"    </a>",
"    ]. Another study showed a trend toward less severe eye findings in prepubertal as compared with postpubertal children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/22\">",
"     22",
"    </a>",
"    ]. Ophthalmopathy is more common in patients who smoke cigarettes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3432?source=see_link\">",
"     \"Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with ophthalmopathy may have a gritty feeling or pain in their eyes, and they may have diplopia caused by extraocular muscle dysfunction. Corneal ulceration can occur as a result of proptosis and lid retraction [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with Graves' hyperthyroidism have a diffuse goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/19\">",
"     19",
"    </a>",
"    ]. The surface tends to be smooth, fleshy in consistency, without palpable nodules. A large goiter may cause dysphagia and tracheal compression with complaints of dyspnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hyperthyroidism have an increase in cardiac output, caused by both increased peripheral oxygen needs and increased cardiac contractility. Heart rate is increased, pulse pressure is widened, and peripheral vascular resistance is decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/23\">",
"     23",
"    </a>",
"    ]. Atrial fibrillation, which occurs in 10 to 20 percent of adults with hyperthyroidism, is rare in children. Mitral valve prolapse is two to three times more prevalent in hyperthyroid patients than in normal subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serum lipids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hyperthyroidism tend to have low serum total and high-density lipoprotein (HDL) cholesterol concentrations and a low total",
"    <span class=\"nowrap\">",
"     cholesterol/HDL",
"    </span>",
"    cholesterol ratio. These values increase after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to gain weight or weight loss, despite an increase in appetite, is common. Weight loss is caused primarily by increased calorigenesis, and secondarily by increased gut motility and the associated hyperdefecation and malabsorption. With treatment, children regain lost weight [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/26\">",
"     26",
"    </a>",
"    ]. Hyperphagia may persist after treatment restores euthyroidism, resulting in excessive weight gain in some children.",
"   </p>",
"   <p>",
"    The prevalence of celiac disease and inflammatory bowel disease is probably modestly increased among individuals with autoimmune thyroid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Patients with persistent gastrointestinal symptoms should undergo screening for these diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=see_link\">",
"     \"Clinical manifestations and diagnosis of celiac disease in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=see_link\">",
"     \"Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Musculoskeletal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proximal muscle weakness may be present, with decreased muscle mass and decreased efficiency of muscle contraction [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/29\">",
"     29",
"    </a>",
"    ]. Hypokalemic periodic paralysis (thyrotoxic periodic paralysis) is a rare disorder that may be associated with hyperthyroidism, especially in Asian adolescent boys. In addition, Graves' disease may be associated with myasthenia gravis and thymic enlargement.",
"   </p>",
"   <p>",
"    Thyroid hormone stimulates bone resorption, resulting in increased porosity of cortical bone and reduced volume of trabecular bone [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/30\">",
"     30",
"    </a>",
"    ]. Serum alkaline phosphatase and osteocalcin concentrations are high, indicative of increased bone turnover. The increase in bone resorption may lead to an increase in serum calcium concentrations, thereby inhibiting parathyroid hormone secretion and the conversion of calcidiol (25-hydroxyvitamin D) to calcitriol (1,25-dihydroxyvitamin D). The net effect is osteoporosis and an increased fracture risk in patients with chronic hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17593?source=see_link\">",
"     \"Bone disease with hyperthyroidism and thyroid hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Neuropsychologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tremulousness and tremor are common in hyperthyroidism. The tremor is best demonstrated from the outstretched hands or the tongue. Deep tendon reflexes are hyperactive. Ataxia and chorea which resolve with treatment of hyperthyroidism has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Benign intracranial hypertension, presenting with headache, has been reported in a child with hyperthyroidism. These findings, including papilledema, reversed with treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with hyperthyroidism tend to have greater mood swings and disturbances of behavior, as compared with adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/33\">",
"     33",
"    </a>",
"    ]. Their attention span decreases, they are usually hyperactive, they sleep poorly, and their school performance deteriorates. Among very young children (&lt;4 years), hyperthyroidism may cause neurodevelopmental delay [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many hyperthyroid children are referred to a developmental specialist or child psychiatrist to evaluate emotional and behavioral symptoms before the presence of hyperthyroidism is suspected.",
"   </p>",
"   <p>",
"    Graves' disease has been reported in association with moyamoya disease, a cerebrovascular disorder characterized by severe bilateral stenosis of the terminal portions of the carotid arteries with prominent collateral circulation and cerebral ischemic events or epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/35\">",
"     35",
"    </a>",
"    ]. Although it is rare, moyamoya disease should be considered in patients with Graves' disease and focal neurological symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3786?source=see_link\">",
"     \"Moyamoya disease: Etiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin is warm in hyperthyroidism because of increased blood flow; it is also smooth because of a decrease in the keratin layer [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/36\">",
"     36",
"    </a>",
"    ]. Sweating is increased because of increased calorigenesis. Onycholysis (loosening of the nails from the nail bed, Plummer's nails) and softening of the nails and thinning of the hair may occur. Vitiligo and alopecia areata can occur in association with autoimmune disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many children and adolescents, the presence of hyperthyroidism is obvious from the history and physical examination, once it is considered. It should be confirmed by measurements of serum thyroid function tests [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/37\">",
"     37",
"    </a>",
"    ]. Serum TSH is suppressed, and free thyroxine (T4) and triiodothyronine (T3) are elevated for age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After thyroid function testing confirms that the patient is hyperthyroid, the next step in the diagnostic evaluation is to determine the cause of hyperthyroidism. The various etiologies can be distinguished by the clinical examination, serum antithyroid antibody measurement, and radioactive iodine uptake (",
"    <a class=\"graphic graphic_table graphicRef58890 \" href=\"UTD.htm?21/37/22109\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Differential diagnosis of thyrotoxicosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The most common cause of hyperthyroidism in children is Graves' disease; other etiologies make up fewer than 10 percent of cases. Thus, the evaluation typically begins by measurement of thyrotropin receptor-stimulating antibody (TRS-Ab) to confirm Graves' disease as the etiology. The most accurate TRS-Ab test is a measurement of thyroid stimulating immunoglobulin (TSI). TSI is a functional assay, confirming the presence of a stimulating antibody. TSI is detectable in approximately 90 percent of children with Graves' hyperthyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative TRS-Ab test is thyrotropin binding inhibitor immunoglobulin (TBII). This test shows that there is an antibody that competes with TSH binding to its receptor, but it does not provide information about whether it is a stimulating or blocking antibody. One study of 57 children with Graves' disease actually reported that TBII was positive in all patients measured (n=18), while TSI was positive in only 57 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/39\">",
"     39",
"    </a>",
"    ]. Thus, TBII may be helpful in establishing a diagnosis of Graves' disease in patients with typical symptoms and signs but in whom TSI is negative.",
"   </p>",
"   <p>",
"    An elevated TSI confirms the diagnosis of Graves' disease. If the TSI level is not elevated, the next step is to perform radioactive iodine (RAI) uptake. 123-I is the radionucleotide of choice for thyroid uptake and scans, as it has a shorter half-life (13.2 hours) and delivers a much smaller radiation dose to the thyroid gland as compared with 131-I. The RAI uptake is elevated in Graves' disease, and the accompanying scan typically will show diffuse uptake throughout the gland, confirming the diagnosis of Graves' hyperthyroidism. The RAI uptake and scan also will help to delineate etiologies other than Graves' disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS OF THYROTOXICOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term hyperthyroidism refers to overproduction of thyroid hormone by the thyroid gland, while the term \"thyrotoxicosis\" refers to the clinical and biochemical manifestations of excess thyroid hormones. Most cases of thyrotoxicosis are associated with hyperthyroidism, particularly in children. However, in a few children with autoimmune thyroiditis, thyrotoxicosis is caused by excessive release of preformed thyroid hormones. The causes of hyperthyroidism and thyrotoxicosis in children are described below (",
"    <a class=\"graphic graphic_table graphicRef58890 \" href=\"UTD.htm?21/37/22109\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Graves' disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the most common cause of hyperthyroidism in children is Graves' disease. In children with hyperthyroidism, the presence of ophthalmopathy strongly suggests the diagnosis of Graves' disease. Even in children with hyperthyroidism who have a goiter but who lack ophthalmopathy, Graves' disease is still the most likely cause.",
"   </p>",
"   <p>",
"    TSH receptor antibodies are detectable in 60 to 90 percent of children with Graves' hyperthyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. When antibodies are not detected, the diagnosis can be confirmed by a 24-hour RAI uptake scan that shows diffuse increased uptake. Alternatively, measurement of thyrotropin binding inhibitor immunoglobulin (TBII) may allow a serologic diagnosis of Graves' disease. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnostic evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The treatment of Graves' disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25400?source=see_link\">",
"     \"Treatment and prognosis of Graves' disease in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740582\">",
"    <span class=\"h3\">",
"     Chronic lymphocytic thyroiditis with thyrotoxic phase: \"hashitoxicosis\"",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic lymphocytic thyroiditis, or \"Hashimoto's thyroiditis\", generally causes hypothyroidism due to destruction of thyroid tissue. However, approximately 5 to 10 percent of children present with a thyrotoxic phase, sometimes termed \"hashitoxicosis\". Clinically, it is different from Graves' hyperthyroidism in that the thyrotoxicosis typically has a shorter course, lasting a few months rather than years, and Graves' ophthalmopathy is absent. Anti-thyroglobulin antibodies (Tg Ab) and thyroid peroxidase antibodies (TPO Ab) are commonly positive, while TRS-Ab (TSI) is negative. RAI uptake is typically low or absent, and a scan will show an inhomogeneous picture [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this disorder, thyrotoxicosis is usually caused by inflammation and autonomous release of preformed, stored thyroid hormone. As a result, antithyroid drug treatment is not effective; patients can be treated with beta-adrenergic antagonists until the thyrotoxicosis resolves.",
"   </p>",
"   <p>",
"    Whether hashitoxicosis is a distinct entity remains controversial, because its clinical features and mechanisms overlap with both Graves' disease and with subacute lymphocytic (painless) thyroiditis. Furthermore, some children with Graves' disease have a preceding history of Hashimoto's thyroiditis. In one series, 4 of 109 children with Graves' hyperthyroidism previously had been diagnosed with Hashimoto's thyroiditis (with associated hypothyroidism or euthyroidism) from 1.5 to 2.8 years prior to the diagnosis of Graves' disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients with hashitoxicosis appear to produce both thyroid-stimulating antibodies (TRS-Ab, as do patients with Graves' disease), and thyroid-blocking antibodies (TRB-Ab). The clinical course depends on which antibody predominates, and the patients tend to undergo cycles of hyper- and hypothyroidism. As an example, one report described 69 children with autoimmune thyroiditis, eight of whom were considered to have hashitoxicosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/40\">",
"     40",
"    </a>",
"    ]. As is typical in hashitoxicosis, the duration of hyperthyroidism was shorter than in Graves' disease, ranging from 31 to 168 days. However, a minority of these patients had elevated radioiodine uptake or mildly increased TSI levels, consistent with a form of hyperthyroidism that is mediated by thyroid-stimulating antibodies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740591\">",
"    <span class=\"h3\">",
"     Subacute granulomatous thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute thyroiditis, also known as de Quervain's disease or painful thyroiditis, is rare in childhood. It is characterized by painful swelling of the thyroid gland, and most likely it is caused by a viral infection. The inflammation results in autonomous release of preformed, stored thyroid hormone, resulting initially in a thyrotoxic phase, followed by euthyroidism, then hypothyroidism, and usually returning to euthyroidism. Thyroid antibodies are negative; RAI uptake is low or absent during the thyrotoxic phase. During the thyrotoxic phase, patients can be treated with beta-adrenergic antagonists. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=see_link\">",
"     \"Overview of thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26182332\">",
"    <span class=\"h3\">",
"     Acute suppurative thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with an acute bacterial infection of the thyroid gland remain euthyroid; transient thyrotoxicosis in a six-year-old child has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10312?source=see_link\">",
"     \"Suppurative thyroiditis in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740599\">",
"    <span class=\"h3\">",
"     Solitary thyroid nodule and hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solitary nodules, or \"toxic adenomas\", are an uncommon cause of hyperthyroidism in childhood. They are suspected in the setting of hyperthyroidism and palpation of a nodule on neck examination. Most such nodules are autonomously functioning \"toxic adenomas\"; many of these have been shown to be the result of TSH receptor-activating mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Thyroid adenomas typically produce T3, so serum testing may show an elevated T3 and suppressed TSH, with a normal or elevated FT4. Thyroid antibodies, including TSI, are negative. RAI uptake and scan will show uptake only in the functioning nodule, with the rest of the gland suppressed. The hyperthyroidism can be treated with antithyroid drugs, but ultimately, most are managed by surgical resection of the adenoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740606\">",
"    <span class=\"h3\">",
"     Toxic multinodular goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxic multinodular goiters are another relatively uncommon cause of hyperthyroidism in children. They are suspected in the setting of hyperthyroidism and palpation of a goiter with multiple nodules. An ultrasound examination is generally undertaken, as it is more sensitive than physical examination in detecting multiple nodules. Antithyroid antibodies, including TSI, are negative. Generally, an RAI uptake and scan is indicated to separate this condition from the thyrotoxic phase of chronic lymphocytic thyroiditis (\"Hashitoxicosis\"), or subacute granulomatous thyroiditis. The uptake will be elevated and seen in the multiple nodules. Some cases of toxic multinodular goiter have been shown to be the result of TSH receptor activating mutations, as described for solitary nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, approximately one-third of children with McCune-Albright syndrome develop hyperthyroidism and a multinodular goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/45\">",
"     45",
"    </a>",
"    ]. McCune-Albright syndrome, caused by an activating mutation of the alpha subunit of the G protein, is characterized by caf&eacute;-au-lait pigmentary skin lesions, fibrous dysplasia of the bones, and precocious puberty. Again, while the hyperthyroidism can be treated with antithyroid drugs, eventually a more permanent form of treatment, such as surgical thyroidectomy or RAI ablation, must be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link&amp;anchor=H3989453#H3989453\">",
"     \"Definition, etiology, and evaluation of precocious puberty\", section on 'McCune-Albright syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740613\">",
"    <span class=\"h3\">",
"     Iodine-induced hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iodine-induced hyperthyroidism typically occurs in patients with preexisting autonomously functioning nodules as part of a multinodular goiter. It occurs primarily in elderly men, and is rare in children. Prior to iodine exposure, patients are euthyroid, though serum TSH may be suppressed. Iodine exposure, eg, as with contrast agents or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/46\">",
"     46",
"    </a>",
"    ], induces thyrotoxicosis. RAI uptake is increased. Symptoms can be managed with beta-adrenergic antagonists until the thyrotoxicosis resolves spontaneously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=see_link&amp;anchor=H7#H7\">",
"     \"Disorders that cause hyperthyroidism\", section on 'Iodine-induced hyperthyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740620\">",
"    <span class=\"h3\">",
"     Neck trauma-induced thyrotoxicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant neck trauma can result in thyrotoxicosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/47\">",
"     47",
"    </a>",
"    ]. This is another form of \"destructive\" thyrotoxicosis. Ultrasonography will usually show evidence of injury, and RAI uptake is decreased in the area of injury. Thyroid function tests gradually normalize over three to six weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26182339\">",
"    <span class=\"h3\">",
"     Radiation-induced thyrotoxicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthyroidism was reported in 23 of 3579 (0.6 percent) childhood survivors of acute lymphoblastic leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/48\">",
"     48",
"    </a>",
"    ]. This appears to be a destructive thyrotoxicosis associated with craniospinal radiation; chemotherapy did not appear to be a risk factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740627\">",
"    <span class=\"h3\">",
"     Pituitary TSH-secreting adenoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;TSH-secreting adenomas are rare at any age, and only a few cases have been reported in children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/49\">",
"     49",
"    </a>",
"    ]. Laboratory testing typically shows an elevated FT4 with a normal (not suppressed) TSH level. The diagnosis is made by finding a high serum TSH alpha subunit concentration, high alpha subunit to TSH ratio, and little or no TSH response to TRH. A pituitary adenoma is confirmed on MRI. Treatment is surgical resection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/20/327?source=see_link\">",
"     \"Thyrotropin (TSH)-secreting pituitary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740634\">",
"    <span class=\"h3\">",
"     Resistance to thyroid hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resistance to thyroid hormone is an autosomal dominant disorder usually due to a mutation in the thyroid hormone beta receptor gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Children commonly present with a goiter and elevated serum FT4 and, to a lesser extent, T3 levels, while TSH is normal or slightly elevated. The serum TSH alpha subunit is not elevated, and serum TSH will increase with TRH stimulation. Children with generalized resistance to thyroid hormone are usually euthyroid, while those with more pituitary resistance may manifest thyrotoxic clinical features.",
"   </p>",
"   <p>",
"    Attempts have been made to try to distinguish pituitary resistance to thyroid hormone from generalized resistance to thyroid hormone by measuring other biochemical markers of hyperthyroidism (eg, serum cholesterol, ferritin, and sex hormone binding globulin) or by measuring the basal metabolic rate. Children with generalized resistance to thyroid hormone probably are not helped by any treatment. Children with more pituitary resistance may need some form of treatment of their hyperthyroidism, such as partial thyroidectomy or RAI ablation. However, such patients will be at risk for pituitary thyrotroph hypertrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4740641\">",
"    <span class=\"h3\">",
"     Factitious thyrotoxicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Factitious thyrotoxicosis should be suspected in the setting of hyperthyroidism but absent goiter. It is most commonly seen in an adolescent with access to thyroxine who is trying to lose weight. Measurement of serum thyroglobulin is useful, as it is elevated in all the endogenous forms of hyperthyroidism, but low in factitious thyrotoxicosis. RAI uptake will also be low or absent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4165?source=see_link&amp;anchor=H2#H2\">",
"     \"Exogenous hyperthyroidism\", section on 'Causes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26182354\">",
"    <span class=\"h3\">",
"     Normal free T4 with suppressed TSH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some children who undergo thyroid function tests for a suspected thyroid disorder manifest suppressed serum TSH levels but normal free T4 levels. In one study, follow-up testing of 23 such children over a several month period showed that 14 returned to euthyroidism, four developed hypothyroidism, four maintained a suppressed TSH but normal free T4, while two progressed to overt hyperthyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7641/abstract/52\">",
"     52",
"    </a>",
"    ]. Thus, it seems prudent to follow such children with serial testing to determine whether a thyroid disorder requiring treatment develops or whether thyroid function returns to normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Graves' disease is by far the most common cause of hyperthyroidism in children and adolescents, and usually presents during early adolescence. It is characterized by excessive thyroid hormone production, caused by thyrotropin (TSH) receptor-stimulating antibodies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations of hyperthyroidism include modest acceleration of linear growth and epiphyseal maturation but delayed puberty, weight loss or failure to gain weight, excessive retraction of the eyelids causing lid lag and stare, diffuse goiter, tachycardia and increased cardiac output, increased gastrointestinal motility, proximal muscle weakness, tremor, hyperreflexia, sleep disturbance, and distractibility. Children with Graves' disease (but not those with other forms of hyperthyroidism) frequently have ophthalmopathy, with proptosis and a gritty sensation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hyperthyroidism is suspected on the basis of the above clinical findings and confirmed by measurement of serum thyroid function tests. Serum TSH is suppressed and free thyroxine (T4) and triiodothyronine (T3) are elevated for age. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with suspected or confirmed hyperthyroidism, TSH receptor-stimulating antibodies (TRS-Ab) should be measured. Measurement of thyroid stimulating immunoglobulin (TSI) is the most accurate measure of TSH receptor-stimulating antibodies. TSI will be positive in 60 to 90 percent of children with Graves' disease. If TSI is not elevated, then a radioactive iodine uptake (RAI) should be performed; elevated RAI with a diffuse pattern is typical of Graves' disease. Alternatively, some patients without an elevated TSI will have elevation of thyrotropin binding inhibitor immunoglobulin (TBII). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Graves' disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of hyperthyroidism in children include chronic lymphocytic thyroiditis with thyrotoxic phase (\"Hashitoxicosis\"), subacute thyroiditis (\"de Quervain disease\"), toxic adenoma, toxic multinodular goiter, pituitary resistance to thyroid hormone, and factitious thyrotoxicosis (",
"      <a class=\"graphic graphic_table graphicRef58890 \" href=\"UTD.htm?21/37/22109\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Other'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/1\">",
"      Williamson S, Greene SA. Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland. Clin Endocrinol (Oxf) 2010; 72:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/2\">",
"      Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. J Pediatr 1977; 91:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/3\">",
"      Poyrazo��lu S, Saka N, Bas F, et al. Evaluation of diagnosis and treatment results in children with Graves' disease with emphasis on the pubertal status of patients. J Pediatr Endocrinol Metab 2008; 21:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/4\">",
"      Brix TH, Kyvik KO, Christensen K, Heged&uuml;s L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001; 86:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/5\">",
"      Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993; 329:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/6\">",
"      Acuna OM, Athannassaki I, Paysse EA. Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease. Trans Am Ophthalmol Soc 2007; 105:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/7\">",
"      Shulman DI, Muhar I, Jorgensen EV, et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997; 7:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/8\">",
"      Manka&iuml; A, Chadli-Chaieb M, Saad F, et al. Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies. Gastroenterol Clin Biol 2006; 30:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/9\">",
"      Koves IH, Cameron FJ, Kornberg AJ. Ocular myasthenia gravis and Graves disease in a 10-year-old child. J Child Neurol 2009; 24:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/10\">",
"      Panamonta O, Sumethkul V, Radinahmed P, et al. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. J Pediatr Endocrinol Metab 2008; 21:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/11\">",
"      Friedman JM, Fialkow PJ. The genetics of Graves' disease. Clin Endocrinol Metab 1978; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/12\">",
"      Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, et al. Hyperthyroidism in a population with Down syndrome (DS). Clin Endocrinol (Oxf) 2009; 71:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/13\">",
"      De Luca F, Corrias A, Salerno M, et al. Peculiarities of Graves' disease in children and adolescents with Down's syndrome. Eur J Endocrinol 2010; 162:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/14\">",
"      Wasniewska M, Corrias A, Messina MF, et al. Graves' disease prevalence in a young population with Turner syndrome. J Endocrinol Invest 2010; 33:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/15\">",
"      Zimmerman D, Gan-Gaisano M. Hyperthyroidism in children and adolescents. Pediatr Clin North Am 1990; 37:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/16\">",
"      Bossowski AT, Reddy V, Perry LA, et al. Clinical and endocrine features and long-term outcome of Graves' disease in early childhood. J Endocrinol Invest 2007; 30:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/17\">",
"      Cassio A, Corrias A, Gualandi S, et al. Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study. Clin Endocrinol (Oxf) 2006; 64:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/18\">",
"      Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 1983; 4:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/19\">",
"      Nordyke RA, Gilbert FI Jr, Harada AS. Graves' disease. Influence of age on clinical findings. Arch Intern Med 1988; 148:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/20\">",
"      Chan W, Wong GW, Fan DS, et al. Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 2002; 86:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/21\">",
"      Goldstein SM, Katowitz WR, Moshang T, Katowitz JA. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review. Thyroid 2008; 18:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/22\">",
"      Holt H, Hunter DG, Smith J, Dagi LR. Pediatric Graves' ophthalmopathy: the pre- and postpubertal experience. J AAPOS 2008; 12:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/23\">",
"      Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab 1994; 78:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/24\">",
"      Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981; 305:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/25\">",
"      O'Brien T, Katz K, Hodge D, et al. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf) 1997; 46:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/26\">",
"      Crocker MK, Kaplowitz P. Treatment of paediatric hyperthyroidism but not hypothyroidism has a significant effect on weight. Clin Endocrinol (Oxf) 2010; 73:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/27\">",
"      Berti I, Trevisiol C, Tommasini A, et al. Usefulness of screening program for celiac disease in autoimmune thyroiditis. Dig Dis Sci 2000; 45:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/28\">",
"      Shah SA, Peppercorn MA, Pallotta JA. Autoimmune (Hashimoto's) thyroiditis associated with Crohn's disease. J Clin Gastroenterol 1998; 26:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/29\">",
"      Z&uuml;rcher RM, Horber FF, Gr&uuml;nig BE, Frey FJ. Effect of thyroid dysfunction on thigh muscle efficiency. J Clin Endocrinol Metab 1989; 69:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/30\">",
"      Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 1994; 4:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/31\">",
"      Seeherunvong T, Diamantopoulos S, Berkovitz GD. A nine year old girl with thyrotoxicosis, ataxia, and chorea. Brain Dev 2007; 29:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/32\">",
"      Merkenschlager A, Ehrt O, M&uuml;ller-Felber W, et al. Reversible benign intracranial hypertension in a child with hyperthyroidism. J Pediatr Endocrinol Metab 2008; 21:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/33\">",
"      Loomba-Albrecht LA, Bremer AA, Styne DM, Glaser NS. High frequency of cardiac and behavioral complaints as presenting symptoms of hyperthyroidism in children. J Pediatr Endocrinol Metab 2011; 24:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/34\">",
"      Segni M, Leonardi E, Mazzoncini B, et al. Special features of Graves' disease in early childhood. Thyroid 1999; 9:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/35\">",
"      Sasaki T, Nogawa S, Amano T. Co-morbidity of moyamoya disease with Graves' disease. report of three cases and a review of the literature. Intern Med 2006; 45:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/36\">",
"      Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 1992; 26:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/37\">",
"      Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/38\">",
"      Botero D, Brown RS. Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease. J Pediatr 1998; 132:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/39\">",
"      Rahhal SN, Eugster EA. Thyroid stimulating immunoglobulin is often negative in children with Graves' disease. J Pediatr Endocrinol Metab 2008; 21:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/40\">",
"      Nabhan ZM, Kreher NC, Eugster EA. Hashitoxicosis in children: clinical features and natural history. J Pediatr 2005; 146:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/41\">",
"      Wasniewska M, Corrias A, Arrigo T, et al. Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. Horm Res Paediatr 2010; 73:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/42\">",
"      Panamonta O, Panombualert S, Panamonta M, Apinives C. Acute suppurative thyroiditis with thyrotoxicosis. J Med Assoc Thai 2009; 92:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/43\">",
"      Polak M. Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 1998; 8:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/44\">",
"      Duprez L, Parma J, Van Sande J, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994; 7:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/45\">",
"      Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/46\">",
"      Hacihamdio��lu B, Berbero��lu M, Siklar Z, et al. Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake. J Pediatr Endocrinol Metab 2010; 23:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/47\">",
"      Kasagi K, Hattori H. A case of destructive thyrotoxicosis induced by neck trauma. Thyroid 2008; 18:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/48\">",
"      Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2009; 53:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/49\">",
"      Nakayama Y, Jinguji S, Kumakura S, et al. Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report. Pituitary 2012; 15:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/50\">",
"      Refetoff S. Resistance to thyroid hormone: an historical overview. Thyroid 1994; 4:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/51\">",
"      Pohlenz J, Weiss RE, Macchia PE, et al. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab 1999; 84:3919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7641/abstract/52\">",
"      Vaidyanathan P, Kaplowitz PB. Evaluation and follow-up of clinically euthyroid children with normal free T4 and suppressed TSH. J Pediatr Endocrinol Metab 2010; 23:993.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5841 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-15E18CE5C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7641=[""].join("\n");
var outline_f7_29_7641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Eyes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Goiter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serum lipids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Musculoskeletal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Neuropsychologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIFFERENTIAL DIAGNOSIS OF THYROTOXICOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740582\">",
"      - Chronic lymphocytic thyroiditis with thyrotoxic phase: \"hashitoxicosis\"",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740591\">",
"      - Subacute granulomatous thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26182332\">",
"      - Acute suppurative thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740599\">",
"      - Solitary thyroid nodule and hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740606\">",
"      - Toxic multinodular goiter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740613\">",
"      - Iodine-induced hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740620\">",
"      - Neck trauma-induced thyrotoxicosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26182339\">",
"      - Radiation-induced thyrotoxicosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740627\">",
"      - Pituitary TSH-secreting adenoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740634\">",
"      - Resistance to thyroid hormone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4740641\">",
"      - Factitious thyrotoxicosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26182354\">",
"      - Normal free T4 with suppressed TSH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5841\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5841|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/37/22109\" title=\"table 1\">",
"      Thyrotoxicosis child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17593?source=related_link\">",
"      Bone disease with hyperthyroidism and thyroid hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=related_link\">",
"      Clinical manifestations and diagnosis of celiac disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=related_link\">",
"      Definition, etiology, and evaluation of precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=related_link\">",
"      Disorders that cause hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=related_link\">",
"      Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/6/97?source=related_link\">",
"      Evaluation and management of neonatal Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4165?source=related_link\">",
"      Exogenous hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3608?source=related_link\">",
"      Laboratory assessment of thyroid function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3786?source=related_link\">",
"      Moyamoya disease: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=related_link\">",
"      Overview of thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3432?source=related_link\">",
"      Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/30/40425?source=related_link\">",
"      Pathogenesis of Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10312?source=related_link\">",
"      Suppurative thyroiditis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/20/327?source=related_link\">",
"      Thyrotropin (TSH)-secreting pituitary adenomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25400?source=related_link\">",
"      Treatment and prognosis of Graves' disease in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7642="Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia";
var content_f7_29_7642=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7642/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7642/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7642/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7642/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/29/7642/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/29/7642/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/29/7642/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive pneumococcal disease is defined as an infection confirmed by the isolation of Streptococcus pneumoniae from a normally sterile site (eg, blood or cerebrospinal fluid, but not sputum). S. pneumoniae (the pneumococcus) is an important and well-known cause of bacteremia in both immunocompetent and immunosuppressed patients. Pneumococcal bacteremia can occur as a result of pneumococcal pneumonia or in its absence. When bacteremia is present, secondary complications, such as arthritis, meningitis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endocarditis, may occur.",
"   </p>",
"   <p>",
"    This topic review will focus on the epidemiology, clinical manifestations, diagnosis, and treatment of pneumococcal bacteremia and selected aspects of other forms of invasive pneumococcal infections, such as meningitis, endocarditis, peritonitis, and various focal infections. The clinical features, epidemiology, and treatment of pneumococcal pneumonia and meningitis, as well as vaccination against S. pneumoniae and the microbiology and pathogenesis of S. pneumoniae are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=see_link\">",
"     \"Pneumococcal pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=see_link\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of invasive pneumococcal disease in any population is affected by geographic location, time of year, serotype prevalence, age, comorbidities, and vaccination status. The highest incidence of invasive pneumococcal disease occurs in adults &ge;65 years of age, in children &lt;2 years of age, and in those with certain underlying conditions, such as HIV infection. According to the United States Active Bacterial Core surveillance (ABCs) database of the Emerging Infections Program Network, in 2010, the incidence of invasive pneumococcal disease in individuals &ge;65 years of age was 36.4 cases per 100,000 population and in infants &lt;1 year, the incidence was 34.2 cases per 100,000 population, compared with 3.8 cases per 100,000 population in individuals between 18 and 34 years of age (",
"    <a class=\"graphic graphic_table graphicRef88701 \" href=\"UTD.htm?1/33/1565\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/1\">",
"     1",
"    </a>",
"    ]. However, some subgroups in this age range have markedly higher risks. For example, in adults aged 18 to 64 years of age with a hematologic malignancy, the incidence was 186 per 100,000 population and for individuals with HIV infection, the incidence was 173 per 100,000 population in 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Impact of childhood vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall incidence of invasive pneumococcal disease in the United States declined following the introduction and widespread use of the pneumococcal conjugate vaccine in children, beginning in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=see_link\">",
"     \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link&amp;anchor=H9#H9\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\", section on 'Invasive disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ABCs database of the Emerging Infections Program Network noted the following impact of childhood pneumococcal conjugate vaccine (7 serotypes, PCV7) on invasive pneumococcal disease through 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Routine vaccination in young children caused statistically significant declines in the incidence of invasive pneumococcal disease in children &lt;5 years (the age group targeted for vaccination), older children, and adults.",
"     </li>",
"     <li>",
"      In 2003, twice as many cases of invasive pneumococcal disease were prevented through indirect effects on pneumococcal transmission (eg, herd immunity) than through its direct effect of protecting vaccinated children (20,459 cases prevented by indirect compared with 9140 cases prevented by direct effects of vaccination).",
"     </li>",
"     <li>",
"      An increase in disease caused by pneumococcal serotypes not included in the vaccine (termed &ldquo;replacement strains&rdquo;) occurred but was less than the overall decline in vaccine-serotype disease (4721 cases of nonvaccine disease compared to 29,599 vaccine-serotype disease decline; net decline 24,878 cases).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar trends since the introduction of PCV7 in 2000 have been noted in several additional studies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/8-13\">",
"     8-13",
"    </a>",
"    ]. Examples of the findings in these studies include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In Atlanta, Georgia, between 2000 and 2004, there were significant reductions in the rates of invasive pneumococcal pneumonia (relative risk [RR] 0.80 in adults and 0.60 in children), pneumococcal meningitis (RR 0.41 in adults and 0.70 in children), and primary pneumococcal bacteremia (RR 0.16 in children) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Between 1998 and 2005 in the United States, a significant reduction in the incidence of pneumococcal meningitis occurred (from 1.13 cases per 100,000 in 1998 to 1999 to 0.79 case per 100,000 in 2004 to 2005), with even larger reductions among those less than two years of age and &ge;65 years of age. Rates of pneumococcal meningitis caused by serotypes included in PCV7 decreased from 0.66 to 0.18 case per 100,000 over the same period [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/9\">",
"       9",
"      </a>",
"      ]. However, the incidence of pneumococcal meningitis caused by non-PCV7 serotypes increased from 0.32 to 0.51 case per 100,000. In an observational cohort study of the impact of PCV7 in England and Wales from 2000 to 2010, the incidence of invasive pneumococcal disease caused by serotypes covered by the vaccine decreased in all age groups [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/11\">",
"       11",
"      </a>",
"      ]. Incidence rates of vaccine-type invasive disease declined by 98 percent in children younger than two years of age and by 81 percent in adults &gt;64 of age. Even though the incidence of non-vaccine-type invasive disease increased by 68 percent in children younger than two years of age and by 48 percent in adults &gt;64 years of age during the same time span, the overall reduction of disease in these two age groups was 56 percent and 19 percent, respectively.",
"     </li>",
"     <li>",
"      Significant decreases in case-fatality and mortality rates were also observed in Minnesota [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/10\">",
"       10",
"      </a>",
"      ]. The case-fatality rate for invasive pneumococcal disease decreased from 19 percent in 1995 to 1999 to 5 percent in 2001 to 2007. The largest decrease in mortality occurred among individuals &ge;65 years of age (from 31 to 8 percent) and in those with invasive pneumonia (from 22 to 7 percent). The overall mortality rate for invasive pneumococcal disease decreased from 2.9 deaths per 100,000 person-years in 1995 to 1999 to 0.7 deaths per 100,000 person-years in 2001 to 2007.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Childhood vaccination also appears to decrease the incidence of invasive pneumococcal disease among HIV-infected adults. Invasive pneumococcal disease among adults infected with HIV living in seven surveillance areas in the United States decreased from 1127 to 919 cases per 100,000 between 1998 and 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/14\">",
"     14",
"    </a>",
"    ]. During the same time period, disease caused by vaccine-containing serotypes decreased 62 percent, whereas disease caused by nonvaccine serotypes increased by 44 percent. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'HIV infection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In contrast to the overall benefit observed in the United States from childhood pneumococcal vaccination, overall rates of invasive pneumococcal disease have increased in Barcelona, Spain since the use of PCV7 became widespread [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/15\">",
"     15",
"    </a>",
"    ]. The increase in invasive infections due to pneumococcal serotypes not included in PCV7 was greater than the reduction in invasive infections due to the serotypes included in PCV7. The significance of these findings remains unknown.",
"   </p>",
"   <p>",
"    A similar pattern was observed in one study in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/16\">",
"     16",
"    </a>",
"    ]. Over a six-year period, the annual rate of bacteremic pneumococcal disease due to vaccine serotypes was reduced by 29 percent per year, but the annual rate of disease due to nonvaccine serotypes increased by 13 percent per year, resulting in on overall 7 percent increase in the annual rate of disease among adults. The presence of children in the home was associated with a decreased risk of infection among adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Drug-resistant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most surveillance data have shown a decline in the proportion of pneumococcal isolates from patients with invasive infections that are nonsusceptible to penicillin and other antibiotics after PCV7 was added to the routine childhood immunization schedule. As an example, data from Active Bacterial Core surveillance areas in the United States indicate that rates of penicillin-nonsusceptible invasive pneumococcal disease among children younger than five years declined by 64 percent between 1998 to 1999 and 2007 to 2008 (ie, before and after the introduction of PCV7, respectively; but before replacement of PCV7 with PCV13 in 2010); similarly, rates of penicillin-nonsusceptible invasive pneumococcal disease among adults &ge;65 years of age declined by 45 percent between these two time periods, suggesting a herd effect [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/17\">",
"     17",
"    </a>",
"    ]. Rates of invasive pneumococcal disease nonsusceptible to multiple antibiotics also declined.",
"    <br/>",
"    <br/>",
"    This issue is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=see_link&amp;anchor=H10#H10\">",
"     \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\", section on 'Antibiotic resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Importance of serotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of invasive disease appears to be closely related to which serotype is present [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. The magnitude of this effect was addressed in a meta-analysis that evaluated isolates from patients with invasive disease and nasal or nasopharyngeal isolates from asymptomatic children in seven different locations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/18\">",
"     18",
"    </a>",
"    ]. Certain serotypes (eg, serotypes 1, 5, and 7) were up to 60 times more likely to be found in patients with invasive disease than other serotypes (eg, serotypes 3, 6A, and 15) commonly isolated from asymptomatic individuals. In addition, there was a significant inverse correlation between invasive disease and the prevalence of nasopharyngeal carriage; the serotypes most commonly isolated from patients with invasive disease were the serotypes least commonly isolated from asymptomatic carriers and vice versa.",
"   </p>",
"   <p>",
"    Serotype also may be an important determinant of the severity of pneumococcal meningitis. As an example, in a study of patients with pneumococcal meningitis in Denmark, serotype 1 was associated with a much lower case-fatality rate than serotype 3 (3 versus 23 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H31#H31\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The possible role of serotype in nosocomial pneumococcal bacteremia was addressed in a prospective review of 796 hospitalized adults with pneumococcal bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/21\">",
"     21",
"    </a>",
"    ]. There was no association between infection with invasive serotypes 1, 5, and 7 and mortality and no difference in disease severity or mortality between infections caused by vaccine and nonvaccine serotypes. On the other hand, mortality was significantly associated with host risk factors, such as age &ge;65 years, immunosuppression, and severity of underlying preexisting diseases.",
"   </p>",
"   <p>",
"    The complexity of the relationship between serotype and the risk of invasive disease was reviewed in an editorial that accompanied the above study [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive and noninvasive clones may exist within invasive serotypes.",
"     </li>",
"     <li>",
"      Cell wall components and pilus-like structures in some pneumococcal strains are related to the propensity to cause invasive disease.",
"     </li>",
"     <li>",
"      Capsular polysaccharides, which determine serotype, may impede complement activation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      phagocytosis and therefore promote tissue invasion and bacteremia; in contrast, other pneumococcal virulence factors may be responsible for outcome after bacteremia has occurred. If this occurs, studies that examine the impact of serotype on outcome of bacteremia in cohorts that already have bacteremia are not likely to find a relationship between serotype and mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk factors for infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of invasive pneumococcal disease is increased in patients with certain underlying medical conditions or demographic risk factors, including [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/1,2,23-34\">",
"     1,2,23-34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age &lt;2 or &ge;65 years (",
"      <a class=\"graphic graphic_table graphicRef88701 \" href=\"UTD.htm?1/33/1565\">",
"       table 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Certain",
"      <span class=\"nowrap\">",
"       racial/ethnic",
"      </span>",
"      groups, including people of African descent, Alaskan Natives, and American Indians",
"     </li>",
"     <li>",
"      Chronic cardiovascular disease (eg, heart failure, cardiomyopathy)",
"     </li>",
"     <li>",
"      Chronic pulmonary disease (eg, chronic obstructive pulmonary disease, emphysema, asthma)",
"     </li>",
"     <li>",
"      Chronic liver disease (eg, cirrhosis)",
"     </li>",
"     <li>",
"      Chronic renal failure or nephrotic syndrome",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Alcohol abuse",
"     </li>",
"     <li>",
"      Smoking",
"     </li>",
"     <li>",
"      Crack cocaine use",
"     </li>",
"     <li>",
"      Functional or anatomic asplenia (eg, sickle cell disease, splenectomy)",
"     </li>",
"     <li>",
"      Immunosuppressive conditions (eg, HIV infection, congenital immunodeficiency, malignancy, B-cell defects, multiple myeloma)",
"     </li>",
"     <li>",
"      Solid organ or hematopoietic cell transplant recipients",
"     </li>",
"     <li>",
"      Patients undergoing treatment with alkylating agents, antimetabolites, or systemic glucocorticoids",
"     </li>",
"     <li>",
"      Patients with cerebrospinal fluid leaks",
"     </li>",
"     <li>",
"      Cochlear implant recipients (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35913?source=see_link&amp;anchor=H7#H7\">",
"       \"Cochlear implant infections\", section on 'Microbiology'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of invasive pneumococcal disease seems to be associated with the presence of viral respiratory illnesses, such as influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. This association may be related to enhanced expression of receptors for pneumococcal attachment on virally activated respiratory epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/35\">",
"     35",
"    </a>",
"    ]. A temporal association between invasive pneumococcal disease and exposure to common respiratory viruses during winter months was observed in a prospective study of 4147 invasive pneumococcal disease episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/37\">",
"     37",
"    </a>",
"    ]. The weekly frequency of invasive pneumococcal disease correlated directly with the weekly frequency of isolation of respiratory syncytial virus (RSV) and influenza.",
"   </p>",
"   <p>",
"    In general, pneumococcal vaccination is recommended for all of the patients in the high-risk groups listed above. Specific recommendations for vaccination can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=see_link&amp;anchor=H5#H5\">",
"     \"Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children\", section on 'Indications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link&amp;anchor=H13#H13\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of HIV infection substantially increases the risk of invasive pneumococcal infection, particularly among those patients with a low CD4 count &lt;200",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/38\">",
"     38",
"    </a>",
"    ]. In a surveillance study conducted from 1994 to 1997 in San Francisco, the incidence of invasive pneumococcal disease was substantially higher in HIV-infected patients compared with the general population (803 versus 35 cases per 100,000 person years) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/39\">",
"     39",
"    </a>",
"    ]. This study was conducted before the availability of the protease inhibitors, and thus the risk of invasive pneumococcal infections in HIV-infected patients on effective antiviral therapy was not assessed.",
"   </p>",
"   <p>",
"    HIV-infected individuals, particularly those not receiving effective antiviral therapy, are at risk for recurrent invasive pneumococcal disease. A retrospective study of all cases of pneumococcal bacteremia that occurred in patients in New York City between 1992 and 1996 found 23 patients had recurrent disease; 87 percent of those with recurrent disease were HIV-infected [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/40\">",
"     40",
"    </a>",
"    ]. This study was also performed before the availability of protease inhibitors. In a study of invasive pneumococcal infections in Baltimore, Maryland between 1995 and 1998, the recurrence rate among HIV-infected individuals was 6.4-fold higher than among individuals without HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/41\">",
"     41",
"    </a>",
"    ]. Most recurrent invasive pneumococcal infections in HIV-infected patients were due to a different serotype than the initial episode. The majority were due to serotypes included in the 23-valent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    and the 7-valent pneumococcal conjugate vaccine, suggesting that many cases of recurrent disease could be prevented. The efficacy and use of pneumococcal vaccines in HIV-infected individuals is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11047?source=see_link\">",
"     \"Pneumococcal immunization in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of invasive pneumococcal infection depend upon the primary site of infection and the presence or absence of bacteremia. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Even with appropriate antimicrobial treatment, pneumococcal meningitis has a mortality rate of 20 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H31#H31\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumococcal endocarditis and other suppurative complications of pneumococcal infections, such as pneumococcal arthritis, ileitis, and pericarditis, were much more common in the preantibiotic era (prior to the early 1940s). This is illustrated by the findings of a review of pneumococcal peritonitis in children hospitalized between 1925 and 1970. Fifty of 56 cases of pneumococcal peritonitis identified in children occurred between 1925 and 1970; only six cases were identified from 1955 to 1970 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pneumococcal endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1881 Osler described the clinical triad of pneumococcal endocarditis, meningitis, and pneumonia. This triad, also called Austrian's syndrome, was thought to be more prevalent in alcoholic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/46\">",
"     46",
"    </a>",
"    ]. In the antibiotic era, 1 to 25 percent of patients with pneumococcal endocarditis have been reported to have the triad [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. However, S. pneumoniae has been responsible for less than 3 percent of all cases of native valve endocarditis since the discovery of penicillin in the early 1940s.",
"   </p>",
"   <p>",
"    Other notable clinical features of patients with pneumococcal endocarditis include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection of the aortic valve is common [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/47,48\">",
"       47,48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infection may occur on valves that were presumed to be morphologically and functionally normal prior to onset of the infection.",
"     </li>",
"     <li>",
"      Onset of infection and the clinical evolution of infection may be acute.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A more detailed discussion of pneumococcal endocarditis is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/37/20058?source=see_link&amp;anchor=H10#H10\">",
"     \"Antimicrobial therapy of native valve endocarditis\", section on 'Pneumococcus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other manifestations of invasive pneumococcal disease including abdominal infections (eg, peritonitis, appendicitis, terminal ileitis) have been primarily described in case reports or small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. These infections may occur with or without concurrent or recently detected bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/49\">",
"     49",
"    </a>",
"    ]. S. pneumoniae may cause suppurative abdominal complications, such as peritonitis and ileitis, particularly in patients with nephrotic syndrome.",
"   </p>",
"   <p>",
"    Purulent pericarditis, septic arthritis, osteomyelitis, and epidural and brain abscess due to S. pneumoniae are rarely recognized in modern practice [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/52-56\">",
"     52-56",
"    </a>",
"    ]. Pneumococcal tenosynovitis, chorioamnionitis, and abscesses involving the psoas, liver, pancreas, spleen, and kidney are even less common [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/56\">",
"     56",
"    </a>",
"    ]. Despite their rarity, case reports of sporadic cases underscore an important clinical point: S. pneumoniae can cause suppurative infections in almost any site. Furthermore, these localized infections can follow an episode of pneumococcal bacteremia or occur simultaneously with pneumococcal bacteremia. In the former instance, these uncommon focal infections may be erroneously presumed to have arisen de novo.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND LABORATORY FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;General laboratory findings in patients with invasive pneumococcal infections and bacteremia are nonspecific: typically there is a leukocytosis (WBC",
"    <span class=\"nowrap\">",
"     &gt;12,000/mL)",
"    </span>",
"    and anemia is common [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/57\">",
"     57",
"    </a>",
"    ]. Poor prognostic factors in patients with extra-meningitic invasive pneumococcal disease include coma, respiratory failure, shock, elevated liver function tests (alanine aminotransferase, ALT &gt;100",
"    <span class=\"nowrap\">",
"     IU/L),",
"    </span>",
"    or leukopenia (WBC",
"    <span class=\"nowrap\">",
"     &lt;4000/mL).",
"    </span>",
"    These prognostic factors have a particularly strong correlation with mortality in children with invasive pneumococcal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive diagnosis of pneumococcal bacteremia or invasive pneumococcal infection requires the culture of S. pneumoniae from the blood or another normally sterile site. S. pneumoniae is rarely if ever a skin contaminant. Thus, when S. pneumoniae is recovered from blood cultures, it is considered to be a pathogen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/14/11494?source=see_link\">",
"     \"Blood cultures for the detection of bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Antigen tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pneumococcal antigen test is a rapid immunochromatographic membrane assay that detects the presence of C polysaccharide cell wall antigen common to all serotypes of S. pneumoniae. The test is approved for the diagnosis of invasive pneumococcal disease using urine samples and, since most patients with pneumococcal meningitis are also bacteremic, it can also be used for the diagnosis of pneumococcal meningitis (by testing CSF or urine). The utility of this antigen test in blood culture samples is being evaluated, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of pneumococcal antigen testing of blood culture broth from cultures that were flagged as positive by",
"      <span class=\"nowrap\">",
"       BactT/ALERT",
"      </span>",
"      system testing but failed to grow pneumococci by culture, antigen testing improved the yield during one surveillance period, with 43 of 182 samples (24 percent) yielding a positive result; however, during a later surveillance period, antigen testing was positive in only 7 of 221 samples (3.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/59\">",
"       59",
"      </a>",
"      ]. When antigen testing was performed on uninoculated broth, weak positive results were observed.",
"     </li>",
"     <li>",
"      In another study, 43 of 43 (100 percent) blood culture samples that grew S. pneumoniae had positive pneumococcal antigen tests [",
"      <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/60\">",
"       60",
"      </a>",
"      ]. In addition, 3 of 12 blood cultures that grew S. mitis had false-positive results on pneumococcal antigen testing, which is consistent with other studies that have reported false-positive results in patients with bacteremia caused by viridans group streptococci, particularly members of the S. mitis group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further study of the utility of pneumococcal antigen testing on blood culture samples is necessary. Such testing may be useful for the early detection of pneumococcal bacteremia when a Gram stain is positive and cultures are negative. However, false-positive results may occur in some patients with S. viridans (especially S. mitis) bacteremia. Furthermore, weak positive results should be interpreted with caution.",
"   </p>",
"   <p>",
"    The use of pneumococcal antigen tests for the diagnosis of pneumococcal pneumonia and meningitis is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\", section on 'Urinary antigen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\", section on 'Rapid tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;All isolates of S. pneumoniae were uniformly sensitive to penicillin until outbreaks of antibiotic-resistant pneumococci occurred in South Africa in the late 1970s [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since then, pneumococci have developed resistance to several classes of antibiotics, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Beta-lactams",
"     </li>",
"     <li>",
"      Macrolides and lincosamides",
"     </li>",
"     <li>",
"      Tetracyclines",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       Trimethoprim-sulfamethoxazole",
"      </a>",
"     </li>",
"     <li>",
"      Glycopeptides",
"     </li>",
"     <li>",
"      Fluoroquinolones",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A detailed discussion of pneumococcal resistance to these antibiotic classes is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19704?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamines, and ketolides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3369?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Impact of resistance on outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a continuing debate as to whether infection with pneumococcal strains that are resistant to beta-lactam antibiotics affects outcome when infection occurs in extra-meningeal sites.",
"   </p>",
"   <p>",
"    In a large prospective study of 1255 children with extra-meningeal invasive pneumococcal infection, the proportion of susceptible and resistant strains were similar in the 19 children who died compared to those who survived their pneumococcal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/63\">",
"     63",
"    </a>",
"    ]. In a retrospective study also involving children, clinical outcome of extra-meningeal penicillin-resistant pneumococcal infection was more closely related to the clinical condition at the time of presentation than to the level of antimicrobial resistance of the infecting strain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings are at variance with other studies in which treatment of extra-meningeal penicillin-resistant pneumococcal infections with beta-lactam antibiotics was associated with an increased likelihood of a fatal outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The difference between the findings in these studies may have been due to differences in the populations studied. Specifically, one of the two studies that reported an association between the presence of antimicrobial resistance and mortality was conducted in a population with a high prevalence of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/65\">",
"     65",
"    </a>",
"    ] and both studies included adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Furthermore, one of the studies found an association between older age and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of concordant (eg, receipt of an antibiotic with in vitro activity against S. pneumoniae) versus discordant (antibiotic inactive in vitro) therapy on mortality was also assessed at 14 days in a subset of 360 of 844 hospitalized adults with pneumococcal bacteremia receiving monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/67\">",
"     67",
"    </a>",
"    ]. Surprisingly, discordant therapy with penicillins,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26583?source=see_link\">",
"     cefuroxime",
"    </a>",
"    ) did not result in a higher mortality rate. In contrast, discordant therapy with cefuroxime was associated with a significantly higher mortality (36 compared with 6 percent with concordant cefuroxime treatment). The authors hypothesized that inadequate duration of time above the MIC for cefuroxime serum concentration was responsible for the worse outcome in these patients. The statistical evaluation was underpowered to evaluate the impact of monotherapy with a fluoroquinolone or macrolide on the outcome of invasive pneumococcal disease.",
"   </p>",
"   <p>",
"    Suppurative complications such as meningitis, empyema, endocarditis, lung abscess, or pericarditis do not occur more frequently in patients infected with strains of penicillin-resistant S. pneumoniae compared with those infected with penicillin-susceptible strains [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Risk factors for antibiotic nonsusceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for penicillin nonsusceptibility were examined in a prospective international observational study of 844 patients with pneumococcal bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/67\">",
"     67",
"    </a>",
"    ]. Two risk factors were found to be statistically significant using multivariate statistical methods:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of an underlying immunosuppressive condition (HIV infection, splenectomy, hematological malignancy, autoimmune disorder, or transplant or chemotherapy within the preceding four weeks).",
"     </li>",
"     <li>",
"      Prior receipt of antibiotics (defined as use of antibiotics for &ge;1 day in the past three months).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another important issue is the impact of community-wide antibiotic use on the prevalence of antibiotic nonsusceptibility. In one study, the relationship between outpatient antibiotic prescribing and nonsusceptibility among isolates causing invasive pneumococcal disease was evaluated using data from seven of the United States Active Bacterial Core surveillance sites between 1996 and 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/68\">",
"     68",
"    </a>",
"    ]. Outpatient antibiotic prescription data for penicillins, cephalosporins, macrolides, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    were reviewed. Sites with high rates of antibiotic prescribing had a higher proportion of nonsusceptibility among invasive pneumococcal disease isolates to each of the antibiotic classes evaluated. Cephalosporin and macrolide prescribing were associated with penicillin and multidrug nonsusceptibility and invasive serotype 19A infections; serotype 19A isolates are frequently multidrug-resistant. These data suggest that local prescribing patterns contribute to local resistance patterns.",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Approach to management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Debate continues as to whether combination therapy or monotherapy is more appropriate for treatment of known or suspected invasive pneumococcal infection prior to the availability of in vitro susceptibility results. In a retrospective study of 1154 patients with invasive pneumococcal disease, most of whom had bacteremia, the receipt of two antimicrobial agents concurrently was independently associated with decreased 30-day mortality (hazard ratio 0.54, 95% CI 0.34-0.84) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/69\">",
"     69",
"    </a>",
"    ]. The optimal duration of combination therapy is also unknown.",
"   </p>",
"   <p>",
"    Until further studies lead to a better understanding of these issues, we, along with most experts, recommend combination therapy (ie, the use of two antibiotics with different anti-pneumococcal mechanisms of action) for patients with known or suspected invasive pneumococcal infections until susceptibility results are available. This approach is especially important for patients at high risk of resistant organisms. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Risk factors for antibiotic nonsusceptibility'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The choice of an empiric antibiotic regimen chosen for the treatment of suspected or known invasive pneumococcal infections depends upon local patterns of in vitro pneumococcal resistance. In all cases, empiric therapy should be reassessed and then adjusted or simplified if possible after susceptibility results are available. The interpretive breakpoints for S. pneumoniae are presented in the following Table (",
"    <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because concurrent meningitis can often not be definitively excluded at the time of presentation and because the mortality rate is notoriously high during the first 72 hours of treatment, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (15 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 8 to 12 hours if renal function is normal) be given with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (2 g IV every 12 hours) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    (2 g IV every 4 to 6 hours) for the initial treatment of invasive pneumococcal infection. The vancomycin dose should not exceed 2 g per dose or a total daily dose of 60",
"    <span class=\"nowrap\">",
"     mg/kg.",
"    </span>",
"    Serum trough concentrations of vancomycin should range from 15 to 20",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=see_link\">",
"     \"Vancomycin dosing and serum concentration monitoring in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a fluoroquinolone may be a reasonable alternative for patients with allergy to beta-lactam antibiotics, we recommend the use of a third-generation cephalosporin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in patients who do",
"    <strong>",
"     not",
"    </strong>",
"    have a history of type I (IgE-mediated, anaphylactic) allergy to beta-lactams because of their combined superior central nervous system penetration. Vancomycin with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    is the best alternative choice in patients with a history of type I allergy to beta-lactam antibiotics who are not candidates for desensitization. The approach to patients with pneumococcal meningitis and beta-lactam allergy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H22#H22\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Beta-lactam allergy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Empiric therapy should be altered once the laboratory has ascertained susceptibility of the organism.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    should be continued if concern for meningitis still exists and high-level penicillin resistance has been documented, or if the infecting strain has an MIC &gt;1",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    to third-generation cephalosporins (",
"    <a class=\"graphic graphic_table graphicRef81209 \" href=\"UTD.htm?11/55/12158\">",
"     table 3",
"    </a>",
"    ). Following the return of in vitro susceptibility testing, it is reasonable to simplify therapy to penicillin if the isolate is susceptible (for patients with meningitis: penicillin MIC &le;0.06",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    and for patients without meningitis: penicillin MIC &le;2",
"    <span class=\"nowrap\">",
"     mcg/mL).",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     Penicillin G",
"    </a>",
"    (4 million units IV every 4 hours) can be used instead of a third-generation cephalosporin, although it is also reasonable to continue therapy with a third-generation cephalosporin given the excellent efficacy, convenient dosing, and affordability of these agents. A detailed discussion of the treatment of pneumococcal meningitis is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\", section on 'Streptococcus pneumoniae'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Combination therapy should normally not exceed three to four days; monotherapy can usually be used after antimicrobial susceptibility results are available.",
"   </p>",
"   <p>",
"    If empiric monotherapy is chosen, the following agents can be used:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      (2 g IV every 12 hours) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (2 g IV every 4 to 6 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (15 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 8 to 12 hours) adjusted for renal function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We are not aware of data supporting the use of a fluoroquinolone as empiric monotherapy for invasive pneumococcal infections, although on theoretical grounds, such therapy should work.",
"   </p>",
"   <p>",
"    If a fluid collection is identified, it should be drained if possible. Follow-up blood cultures should be obtained after the initiation of therapy, particularly if the patient does not appear to respond to therapy. If blood cultures remain persistently positive despite appropriate therapy, further evaluation for the possibility of endocarditis (with echocardiography) is warranted. Similarly, evaluation for concurrent endocarditis is warranted if signs of valvular dysfunction are present and if sustained bacteremia is documented. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no controlled trials on the optimal duration of antibiotics for the treatment of invasive pneumococcal infection. Several factors should be considered when planning a treatment course:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Location of primary infection",
"     </li>",
"     <li>",
"      Immune status of the host",
"     </li>",
"     <li>",
"      The presence or absence of suppurative complications",
"     </li>",
"     <li>",
"      The response of the patient to therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, uncomplicated bacteremia should be treated with a 10 to 14 day course of appropriate antibiotics, assuming the patient has a good therapeutic response. We recommend initiation with intravenous therapy pending in vitro susceptibility results. Completion of therapy with an oral antibiotic is acceptable if the susceptibility pattern allows. The course of therapy will need to be adjusted if the patient has concurrent invasive pneumococcal infection (eg, endocarditis, septic arthritis, brain abscess) or fails to respond to therapy.",
"   </p>",
"   <p>",
"    The management of pneumococcal meningitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\", section on 'Streptococcus pneumoniae'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Evaluation for risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is debate as to whether evaluation for risk factors of recurrent pneumococcal infection is warranted following the identification of the first attack of invasive pneumococcal disease. Our practice is to recommend an HIV test in all sexually active patients with invasive pneumococcal infections. In addition, we recommend screening tests for the presence of multiple myeloma in elderly patients with invasive pneumococcal infections and coexisting or preexisting anemia. An evaluation for sickle cell disease is recommended in younger patients with invasive pneumococcal infection and genetic risk factors for sickle cell disease (eg, people of African descent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1831831823\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overall mortality rates for patients with pneumococcal bacteremia have consistently ranged from 15 to 20 percent in the antibiotic era. Risk of death in patients with pneumococcal bacteremia is highest during the first 72 hours after bacteremia is identified. In the prospective international observational study described above, the overall mortality rate of pneumococcal bacteremia was 17 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/67\">",
"     67",
"    </a>",
"    ]. Approximately two-thirds of deaths occurred within the first three days following admission to the hospital.",
"   </p>",
"   <p>",
"    Risk factors significantly associated with death in this and another study of pneumococcal bacteremia included [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/21,67\">",
"     21,67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &ge;65 years",
"     </li>",
"     <li>",
"      Severity of illness",
"     </li>",
"     <li>",
"      Presence of an underlying disease or risk factor associated with immunosuppression (especially HIV infection)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In 2010 in the United States, the mortality for individuals &ge;65 years of age was 5.61 deaths per 100,000 population, compared with 0.26 deaths per 100,000 population among individuals between 18 and 34 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/29/7642/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/50/33569?source=see_link\">",
"       \"Patient information: Sepsis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1791179507\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive pneumococcal disease is defined as an infection confirmed by the isolation of Streptococcus pneumoniae from a normally sterile site (eg, blood or cerebrospinal fluid, but not sputum). S. pneumoniae (the pneumococcus) is an important and well-known cause of bacteremia in both immunocompetent and immunosuppressed patients. Pneumococcal bacteremia can occur as a result of pneumococcal pneumonia or in its absence. When bacteremia is present, secondary complications, such as arthritis, meningitis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endocarditis, may occur. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incidence of invasive pneumococcal disease in any population is affected by geographic location, time of year, serotype prevalence, age, comorbidities, and vaccination status. The overall incidence of invasive pneumococcal disease in the United States declined following the introduction and widespread use of the pneumococcal conjugate vaccine in children, beginning in 2000. Routine vaccination in young children caused significant declines in the incidence of invasive pneumococcal disease in children &lt;5 years (the age group targeted for vaccination), older children, and adults. However, an increase in disease caused by pneumococcal serotypes not included in the vaccine (eg, replacement disease) has also been observed. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Impact of childhood vaccination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incidence of invasive pneumococcal disease is increased in patients with certain underlying medical conditions or demographic risk factors, including age &lt;2 or &ge;65 years (",
"      <a class=\"graphic graphic_table graphicRef88701 \" href=\"UTD.htm?1/33/1565\">",
"       table 1",
"      </a>",
"      ); certain",
"      <span class=\"nowrap\">",
"       racial/ethnic",
"      </span>",
"      groups (people of African descent, Alaskan Natives and American Indians); chronic cardiovascular, pulmonary, liver, or renal disease; diabetes mellitus; alcohol abuse; smoking; or immunosuppressive conditions. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Risk factors for infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of invasive pneumococcal infection depend upon the primary site of infection and the presence or absence of bacteremia. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Pneumococcal endocarditis and other suppurative complications of pneumococcal infections, such as pneumococcal arthritis, ileitis, and pericarditis, were much more common in the preantibiotic era. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive diagnosis of pneumococcal bacteremia or invasive pneumococcal infection requires the culture of S. pneumoniae from the blood or another normally sterile site. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Blood cultures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pneumococcal urine antigen test is a rapid immunochromatographic membrane assay that detects the presence of C polysaccharide cell wall antigen common to all serotypes of S. pneumoniae. The test is approved for the diagnosis of invasive pneumococcal disease using urine samples and, since most patients with pneumococcal meningitis are also bacteremic, it can also be used for the diagnosis of pneumococcal meningitis (by testing CSF or urine). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Antigen tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend combination therapy (ie, the use of two antibiotics with different anti-pneumococcal mechanisms of action) for patients with known or suspected invasive pneumococcal infections until susceptibility results are available. The choice of an empiric regimen chosen for the treatment of suspected or known invasive pneumococcal infections depends upon local patterns of resistance. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Approach to management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because concurrent meningitis can often not be definitively excluded at the time of presentation and because the mortality rate is notoriously high during the first 72 hours of treatment, we recommend",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (15 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 8 to 12 hours if renal function is normal) be given with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (2 g IV every 12 hours) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (2 g IV every 4 to 6 hours) for the initial treatment of invasive pneumococcal infection. Combination therapy should normally not exceed three to four days; monotherapy can usually be used after antimicrobial susceptibility results are available. The management of pneumococcal meningitis is discussed separately. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Empiric therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link&amp;anchor=H8#H8\">",
"       \"Treatment of bacterial meningitis caused by specific pathogens in adults\", section on 'Streptococcus pneumoniae'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In general, uncomplicated bacteremia should be treated with a 10 to 14 day course of appropriate antibiotics, assuming the patient has a good therapeutic response. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overall mortality rates for patients with pneumococcal bacteremia have consistently ranged from 15 to 20 percent in the antibiotic era. The highest mortality rates are observed in individuals &ge;65 years of age, in those with severe disease, and in immunocompromised hosts. (See",
"      <a class=\"local\" href=\"#H1831831823\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Disease Control and Prevention &mdash; 2011. Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network",
"Streptococcus pneumoniae, 2010. file://www.cdc.gov/abcs/reports-findings/survreports/spneu10-orig.pdf (Accessed on March 21, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/3\">",
"      Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2004; 39:641.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/abcs/index.html (Accessed on February 01, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/6\">",
"      Shah SS, Ratner AJ. Trends in invasive pneumococcal disease-associated hospitalizations. Clin Infect Dis 2006; 42:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/7\">",
"      Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/8\">",
"      Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007; 44:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/9\">",
"      Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/10\">",
"      Tsigrelis C, Tleyjeh IM, Lahr BD, et al. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis 2008; 47:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/11\">",
"      Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/12\">",
"      Rosen JB, Thomas AR, Lexau CA, et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011; 53:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/13\">",
"      Muhammad RD, Oza-Frank R, Zell E, et al. Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis 2013; 56:e59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/14\">",
"      Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/15\">",
"      Ardanuy C, Tubau F, Pallares R, et al. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009; 48:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/16\">",
"      Metlay JP, Lautenbach E, Li Y, et al. Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med 2010; 170:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/17\">",
"      Hampton LM, Farley MM, Schaffner W, et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis 2012; 205:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/18\">",
"      Brueggemann AB, Peto TE, Crook DW, et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/19\">",
"      &Oslash;stergaard C, Brandt C, Konradsen HB, Samuelsson S. Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models. J Infect Dis 2004; 190:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/20\">",
"      Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/21\">",
"      Alanee SR, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/22\">",
"      Garau J, Calbo E. Capsular types and predicting patient outcomes in pneumococcal bacteremia. Clin Infect Dis 2007; 45:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/23\">",
"      Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mort Wkly Rep 1997; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices. Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003; 52:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/25\">",
"      Gentile JH, Sparo MD, Mercapide ME, Luna CM. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Medicina (B Aires) 2003; 63:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/26\">",
"      Laupland KB, Gregson DB, Zygun DA, et al. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004; 32:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/27\">",
"      Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005; 352:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/28\">",
"      Hargreaves RM, Lea JR, Griffiths H, et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol 1995; 48:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/29\">",
"      Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/30\">",
"      Chi RC, Jackson LA, Neuzil KM. Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia. J Am Geriatr Soc 2006; 54:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/31\">",
"      Romney MG, Hull MW, Gustafson R, et al. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis 2008; 47:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/32\">",
"      Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/33\">",
"      Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986; 146:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/34\">",
"      Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med 2009; 150:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/35\">",
"      Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995; 332:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/36\">",
"      Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008; 122:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/37\">",
"      Talbot TR, Poehling KA, Hartert TV, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005; 118:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/38\">",
"      French N, Gordon SB, Mwalukomo T, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/39\">",
"      Nuorti JP, Butler JC, Gelling L, et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/40\">",
"      Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med 2001; 161:2141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/41\">",
"      McEllistrem MC, Mendelsohn AB, Pass MA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002; 185:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/42\">",
"      Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/43\">",
"      Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/44\">",
"      Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/45\">",
"      Fowler R. Primary peritonitis: changing aspects 1956-1970. Aust Paediatr J 1971; 7:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/46\">",
"      AUSTRIAN R. Pneumococcal endocarditis, meningitis, and rupture of the aortic valve. AMA Arch Intern Med 1957; 99:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/47\">",
"      Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) 1985; 290:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/48\">",
"      Aronin SI, Mukherjee SK, West JC, Cooney EL. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 1998; 26:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/49\">",
"      Petti CA, Ignatius Ou SH, Sexton DJ. Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases. Clin Infect Dis 2002; 34:E50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/50\">",
"      Heltberg O, Korner B, Schouenborg P. Six cases of acute appendicitis with secondary peritonitis caused by Streptococcus pneumoniae. Eur J Clin Microbiol 1984; 3:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/51\">",
"      Astagneau P, Goldstein FW, Francoual S, et al. Appendicitis due to both Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1992; 11:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/52\">",
"      Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003; 36:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/53\">",
"      Ryczak M, Sands M, Brown RB, Sklar JH. Pneumococcal arthritis in a prosthetic knee. A case report and review of the literature. Clin Orthop Relat Res 1987; :224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/54\">",
"      Turner DP, Weston VC, Ispahani P. Streptococcus pneumoniae spinal infection in Nottingham, United Kingdom: not a rare event. Clin Infect Dis 1999; 28:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/55\">",
"      Grigoriadis E, Gold WL. Pyogenic brain abscess caused by Streptococcus pneumoniae: case report and review. Clin Infect Dis 1997; 25:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/56\">",
"      Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med 1999; 107:12S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/57\">",
"      Musher DM, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000; 79:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/58\">",
"      Ma JS, Chen PY, Mak SC, et al. Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospective analysis. J Microbiol Immunol Infect 2002; 35:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/59\">",
"      Baggett HC, Rhodes J, Dejsirilert S, et al. Pneumococcal antigen testing of blood culture broth to enhance the detection of Streptococcus pneumoniae bacteremia. Eur J Clin Microbiol Infect Dis 2012; 31:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/60\">",
"      Petti CA, Woods CW, Reller LB. Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia. J Clin Microbiol 2005; 43:2510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/61\">",
"      Appelbaum PC, Bhamjee A, Scragg JN, et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/62\">",
"      Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/63\">",
"      Kaplan SL, Mason EO Jr, Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998; 102:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/64\">",
"      Choi EH, Lee HJ. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 1998; 26:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/65\">",
"      Turett GS, Blum S, Fazal BA, et al. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999; 29:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/66\">",
"      Feikin DR, Schuchat A, Kolczak M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/67\">",
"      Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/68\">",
"      Hicks LA, Chien YW, Taylor TH Jr, et al. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011; 53:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/29/7642/abstract/69\">",
"      Marrie TJ, Tyrrell GJ, Garg S, Vanderkooi OG. Factors predicting mortality in invasive pneumococcal disease in adults in Alberta. Medicine (Baltimore) 2011; 90:171.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3168 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C264CC6E5B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7642=[""].join("\n");
var outline_f7_29_7642=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1791179507\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Impact of childhood vaccination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Drug-resistant disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Importance of serotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk factors for infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pneumococcal endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS AND LABORATORY FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Antigen tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Impact of resistance on outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Risk factors for antibiotic nonsusceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Approach to management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Evaluation for risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1831831823\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1791179507\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3168\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3168|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/33/1565\" title=\"table 1\">",
"      IPD incidence and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/13/16605\" title=\"table 2\">",
"      Susceptibility of pneumococci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/55/12158\" title=\"table 3\">",
"      Meningitis treatment based on susceptibility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/37/20058?source=related_link\">",
"      Antimicrobial therapy of native valve endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/14/11494?source=related_link\">",
"      Blood cultures for the detection of bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35913?source=related_link\">",
"      Cochlear implant infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=related_link\">",
"      Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=related_link\">",
"      Microbiology and pathogenesis of Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/50/33569?source=related_link\">",
"      Patient information: Sepsis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11047?source=related_link\">",
"      Pneumococcal immunization in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=related_link\">",
"      Pneumococcal pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to beta-lactam antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3369?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19704?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamines, and ketolides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=related_link\">",
"      Vancomycin dosing and serum concentration monitoring in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_29_7643="Causes of ovarian torsion";
var content_f7_29_7643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Most common etiologies of torsion in different populations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fetus/neonate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovarian cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Premenarchal girls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovarian cysts and neoplasms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elongated utero-ovarian ligament",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Premenopausal women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovarian cysts and neoplasms (includes ovarian hyperstimulation syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Postmenopausal women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovarian cysts and neoplasms",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7643=[""].join("\n");
var outline_f7_29_7643=null;
var title_f7_29_7644="Epiglottitis microbiology";
var content_f7_29_7644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infectious causes of epiglottitis (supraglottitis)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Bacterial causes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <span class=\"red\">",
"        Haemophilus influenzae type b (Hib)*",
"       </span>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       H. influenzae types A and F, and nontypeable strains",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Haemophilus parinfluenzae",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <span class=\"red\">",
"        Streptococcus pneumoniae",
"       </span>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <span class=\"red\">",
"        Staphylococcus aureus (methicillin susceptible and methicillin resistant)",
"       </span>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <span class=\"red\">",
"        Beta-hemolytic streptococci: Groups A,",
"       </span>",
"       B, C, F, G",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pasteurella multocida",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Moraxella catarrhalis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Klebsiella pneumoniae",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neisseria spp",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Escherichia coli",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Enterobacter cloacae",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pseudomonas aeruginosa&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Viral causes&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Herpes simplex virus type 1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Varicella zoster virus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parainfluenza virus type 3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Influenza B viruses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Epstein-Barr virus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Fungal causes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Candida&bull;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <span class=\"red\">",
"     Red:",
"    </span>",
"    more common causes.",
"    <div class=\"footnotes\">",
"     * The most common cause in children and in adults when an organism is identified.",
"     <br>",
"      &bull; Usually in immunocompromised patients.",
"      <br>",
"       &Delta; Epiglottitis may result from bacterial superinfection.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7644=[""].join("\n");
var outline_f7_29_7644=null;
var title_f7_29_7645="Medications and bronchoprovocation testing";
var content_f7_29_7645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medications that may affect bronchoprovocation challenge test",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Medication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Minimum time to omit medication before challenge tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        <strong>",
"         Inhaled bronchodilators",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Albuterol",
"       </td>",
"       <td>",
"        8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metaproterenol",
"       </td>",
"       <td>",
"        8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Terbutaline",
"       </td>",
"       <td>",
"        8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ipratropium",
"       </td>",
"       <td>",
"        24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Salmeterol",
"       </td>",
"       <td>",
"        48 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Formoterol",
"       </td>",
"       <td>",
"        48 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Tiotropium",
"       </td>",
"       <td>",
"        1 week",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        <strong>",
"         Oral bronchodilators",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Liquid theophylline",
"       </td>",
"       <td>",
"        12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intermediate-acting theophylline",
"       </td>",
"       <td>",
"        24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Long-acting theophylline",
"       </td>",
"       <td>",
"        48 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Albuterol tablet",
"       </td>",
"       <td>",
"        12 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Long-acting albuterol tablet",
"       </td>",
"       <td>",
"        24 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Inhaled glucocorticoid",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        2-3 weeks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Oral glucocorticoid",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        2-3 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        <strong>",
"         Mast cell stabilizers",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Cromolyn sodium",
"       </td>",
"       <td>",
"        8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        <strong>",
"         Antihistamines",
"        </strong>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diphenhydramine",
"       </td>",
"       <td>",
"        72 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chlorpheniramine",
"       </td>",
"       <td>",
"        72 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hydroxyzine",
"       </td>",
"       <td>",
"        72 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Cetirizine",
"       </td>",
"       <td>",
"        72 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        <strong>",
"         Leukotriene modifiers",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Montelukast",
"       </td>",
"       <td>",
"        24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zafirlukast",
"       </td>",
"       <td>",
"        24 hours",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The authors do not recommend routinely withholding inhaled or oral glucocorticoids, but their antiinflammatory effect may decrease bronchial responsiveness. A negative test while the patient is using glucocorticoids implies that the patient's current symptoms are not due to asthma.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Antihistamines are discontinued because of their anticholinergic effect.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7645=[""].join("\n");
var outline_f7_29_7645=null;
var title_f7_29_7646="Survival Budd Chiari syndrome";
var content_f7_29_7646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Statistical model predicting survival in Budd-Chiari syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 313px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Survival for class I (n = 55), class II (n = 95), and class III (n = 55), according to the prognostic classification Ptrend &lt;0.0001, Pclass I versus II = 0.013, Pclass II versus III = 0.0001.",
"    <div class=\"footnotes\">",
"     The following equation was used to cacluate a hazard score:",
"     <br>",
"      1.27 X encephalopathy + 1.04 X ascites + 0.72 X prothrombin time + 0.004 X bilirubin",
"      <br>",
"       <br>",
"        Where ascites and encephalopathy were scored as present (1) or absent (0) and prothrombin time was scored as higher (1) or lower (0) than 2.3 INR. Bilirubin was included as a continuous variable for which the risk increased with 0.004 per micromol/L (0.000234 mg/dL, to convert bilirubin from&nbsp;micromol/L to mg/dL divide by 17.1)",
"        <br>",
"         <br>",
"          Class I: total score between 0 and 1.1",
"          <br>",
"           Class II: total score between 1.1 and 1.5",
"           <br>",
"            Class III: total score &lt;1.5",
"            <br>",
"             * Five-year survival rates.",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Murad SD, Valla DC, De Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39:500. Copyright &copy; 2004 American Association for the Study of Liver Diseases. Permission from John Wiley &amp; Sons International.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7646=[""].join("\n");
var outline_f7_29_7646=null;
var title_f7_29_7647="Average intrapleural distance";
var content_f7_29_7647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumothorax size estimated by the average intrapleural distance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The schematic diagram details the use of the average intrapleural distance to estimate the size of a pneumothorax from a frontal chest radiograph.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helga E Stark, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_29_7647=[""].join("\n");
var outline_f7_29_7647=null;
